CA1037476A - Benzylpyrimidines - Google Patents

Benzylpyrimidines

Info

Publication number
CA1037476A
CA1037476A CA207,509A CA207509A CA1037476A CA 1037476 A CA1037476 A CA 1037476A CA 207509 A CA207509 A CA 207509A CA 1037476 A CA1037476 A CA 1037476A
Authority
CA
Canada
Prior art keywords
dimethoxy
amino
diamino
group
benzyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA207,509A
Other languages
French (fr)
Other versions
CA207509S (en
Inventor
Guido Zanetti
Ivan Kompis
Gerald Rey-Bellet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of CA1037476A publication Critical patent/CA1037476A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

ABSTRACT

Novel benzylpyrimidine derivatives of the general formula wherein R1 and R2 each independently represent a C1-3 alkyl, C1-3 alkoxy, C2-3 alkenyl or C2-3 s alkenyloxy group, Z represents a nitro, amino, pyrrolo, pyrrolidino, piperidino, NHR4, -N(R4)2, -NHR5, -N(R4)(R5), -NR4COOR4, -NHCOOR4, -NHCONHR3, -NHCSNHR3, -N3, -N=N-N(R4)2, -N(NO)R4, or -NR3-NH2 group, R4 represents a C1-3 alkyl or C2-3 alkenyl group, R5 represents an acyl group, R3 represents a hydrogen atom or a C1-3 alkyl or C2-3 alkenyl group, A represents an oxygen atom bonded to one of the cyclic nitrogen atoms and n stands for zero or 1, and salts thereof are prepared by various methods.
The novel compounds possess antibacterial activity and potentiate antibacterially-active sulphonamides.

Description

7~ ~

The present invention relates to benzylpyrimidine derivatives. More particularly, the invention is concerned with benzylpyrimidine derivatives, a process for the manufact-ure thereof and antibacterial compositions containing same.

~he benzylpyrimidine derivati~es provided by the present invention are compounds of the general formula ~1 An Z ~ C H2 ~ \ ~ NH2 (I) , wherein Rl and R2 each independently represent a Cl 3 alkyl, Cl_3 alkoxy, C2_3 alkenyl or C2 3 alkenyloxy group9 Z repreæents a nitro, amino, pgrrolo, p~rrolidino, piperidino, -NHR4 -NtR4) -N~R5 -N(R4)(R5), -NR4CooR 9 -NHCooR4, -~HCoNHR3, -NHCSNHR3, -N3, -N=N-N(R4)2, ~N(No)R4 or ~R3-NH2 group, R4 represents a lS 1 3 Y r C2_3 alkenyl group, R5 repre t an acyl group, R3 represents a hydrogen atom or a Cl 3 alkyl or C2 3 alkenyl group, A represents an oxygen atom bonded to one of the cyc~ nitrogen atoms and n stands for zero or 1, and salts thereof~

~he terms "Cl 3" and "C2 3'~ used in thi9 description Grn/31.7.1974 - 2 - ~

L7~
and in the claims appended hereto denote that the groups prefixed therewith contain 1 3 or 2-3 carbon atoms. The alkyl, - alkoxy, alkenyl and alkenylox~ groups can be straight-chain or branched chain~ Examples of such groups are methyl, ethyl, propyl and isopropyl, methoxy, ethoxy, propoxy and isopropoxy, vinyl and allyl and vinyloxy and allyloxy. ~he acyl groups can be derived from aliphatic, araliphatic, aromatic or hetero-aromatic carboxylic acids or thiocarboxylic acids or from aliphatic or aromatic sulphonic acids. ~he preferred acyl groups are derived from Cl 4 aliphatic monocarboxylic acids (e.g. formyl, acetyl, propionyl, butyryl and ethoxyacetyl), monocyclic aromatic and aromatic sulphonic acids (e.g. benzoyl, toluoyl and tosyl) and aliphatic sulphonic acids (e.g. mesyl).
Examples of hereroaromatic acids are pyridinecarboxylic acids (eOg. nicotinic acid) and thiophenecarboxylic acids. Examples of thiocarboxylic acids are thioacetic acid ~ld thiopropionic acid.

A pre~erred class of compou~ds of formula I hereinbefore compri~es those in which Z represents a nitro9 amino, pyrrolo, pgrrolidino, piperidino, -~HR4, -N(R4)2~ -~HR5, -N~R4)(R5), --NR4cooR49 -NXCooR4~ - NHCoNHR3 or ~N~CSNHR3 group.

Especially preferred compounds of formula I are those in which Z represents a nitro, amino, -N~4~ -N(R4)2, -NHR5, -NR4CooR4, ~HCooR4 or -N3 Kroup.

Of the preferred compounds mentioned hereinbe~ore~ those in which Rl and R2 each represent a Cl 3 alkoxy ~roup, especially a methoxy or ethoxy group, are preferred. Also preferred are :~3~'~1L7~
those compounds in which ~ represents an amino group and n stands for zero.
,:
According to the process provided by the present invention, the benzylpyrimidine derivatives aforesaid (i.e. the compounds of formula I and their salts) are manufactured by a) reacting a compound of the general formula ~;' Rl CN (IIB) \o~6 or ~1 C N
Z ~ ~ C~l2- C ~ (IIb) ,~=/ ~ CHY
R~

~wherein zl represents a nitro, amino~ pyrrolo, . pyrrolidino, piperidino, -NHR4, -N(R4~2, -NHR5, -N(R4)(R5), -NR4CooR4, -NHCooR4, -NHCoNHR3, -NHCSNHR3 or -NR3NH2 group, the ymbol R6 represents a lower alk~l group or the two R~ symbols together represent a lower alkylene group, Y represents a leavin~ group and Rl, R2, R3, R4 and R5 have the si~nificance given earlier, with guanidine, or 7~
c) reductively removing the subs~ituent denoted by X
in a compound of the general formula R NH~
~ N :~.

zl ~ ~ N > (IV) R xl , wherein Xl rcpresents a chlorine or brom:ino atonl or a hydroxy group and Rl, R and Z
have the significance given earlier, or d) diazotising a compound of formula I in which Z
represents an amino group and subsequently reacting the lo product with sodium azide, with an amine of the formula NH~R4~2 or with an alkali sulphi~e, or .. . . .. . .. . . . .

3'79~7~ .
e) treating a compound of formula I in which ~ represents ~ B a NHR4 group with ~ acid, or ~) converting the group z2 in a compound of -the general formula Z~CH2~ NH2 (Va) R

z ~ C H2 ~ ~\ ~ z2 (~b )= N
R2 z2 or R~

Z~3CH2~ \~Z (v~) R2 z , wherein ~1 and R2 ha~e the significance given earlier and z2, which can ba the same or different in formulae Vb and Vc~ represents a group convertible by reduction or hydrolysis into an amino group or a -N~4 group, into an amino group or a -NHR4 group, or ~3~ 76 g) alkylating or a]kenylating the group denoted by Z3 in a com-pound of the general Eormula R \

3 ~ N
~2 2 ,.

, wherein Z3 repreC~ents a -N~1R5 or -N11COOR4 group and Rl, R2, R4 and R5 have thc signlficanco givon carlior, and when recluired converting a compound oE Eormula I obtained into a pharmaceutically acceptable salt thereof.
According to embodiment (a) of the present process, a com-pound of formula IIa or IIb is reacted with guanidine. The symbol Y
in a compound of Eormula IIb represents a leaving group. Examples of suitable leaving groups are ether groups ~e.g. lower alkoxy groups such as methoxy and ethoxy), thioether groups (e.g. alkylthio groups) or amino groups derived from primary or secondary amines. Examples ~;
of such amino groups are i) groups derived from primary aliphatic, aryl-aliphatic or aromatic amines such as lower alkylamino, ben~yl-amino, and arylamino ~e.g. naphthylamino), but especially phenylamino (anilino) which may carry in the phenyl ring one or more "ll ~

.: , . . : . : .

7~
:: halogent lower alkyl or lower alkoxy substituents, or ii) groups derived from secondary aliphatic~ aromatic or he~ero-cyclic amines such as N,N-di(lower alkyl)amino, N-(lower alkyl)--N-arylamino [e.~0 N-methyl-N-phenylamino (N-methylanilino) which may carry in the phenyl ring one or more halogen, lower alkyl or lower alkoxy substituents~, pyrrolidino, piperidino, piperazino and morpholino. An especially preferred amino lea~-ing group i8 the anilino group.

The reaction of a compound of formula IIa or IIb with guanidine can be carried out according to methods known per se;
for example, as desc.ribed in Belgian Patent Spec.if`ications Nos 594,131, 671,982 and 746,846. For exampIe, the reaction can be carried out in a solvent such as an alkanol (e.g. methanol or ethanol), dimethylformamide, dimethyl sulphoxide or N-methyl--pyrazolone at a temperature in the approximate range of from 25C to 200C, preferably at a temperature of from 50C to 170C.

The compounds of formula IIb can be formed in situ under the conditions of the reaction from the tautomeric compounds of the ~eneral formula R~
~_ CN
Z~ CH=(: \ (IIc) ~=/ CH.2Y
R~

, wherein Rl, R2, zl and Y have the significance gi~en earlier.
I`he compounds of formulaeIIb and IIc can occur as the cis or trans isomers or as mixtures thereof.

, ' ' , : , , ~.

Embodiment (a) of the present process leads to compounds of formula I in which n stands for zero, Z has ~ny of the values accorded to ~1 hereinbefore and Rl, R2 and ~1 have the signifi-cance given earlier.

In accordance with embodiment (b) of the present proces~
a compound of formula III is reacted with ammonia, the bromine or chlorine atom or the alkylmercapto or alkylsulphonyl group present in the pyrimidine nucleus being replaced by an amino group. This reaction is conveniently carried out in an alkanolic solution, e~pecially a methanolic solution. In a pre~erred a~pect, the r0action i~ carried out using meth~nolic ~mmonia~
The reaction i~ con~eniently carried out at a temperature between about 80C ~nd 200C, e~pecially at a temperature ~etween about 100C and 150C. Since the~e temperatures lie above the boiling point of methanol, the reaction is then carried out in a closed sy~tem (e.g. in an autocla~e).

E~bodiment (b) of the proces~ lead3 to compounds of ~ormula I in which n st~ndq for zero9 Z ha~ any o~ the values accorded to zl hareinbefore and Rl Rnd R2 have the signific~nce ~ive~ ~arli~r~

~he removal o~ a bromine or chlorine atom rrom a compound of formula IV in accordance with embodiment (c) Or the present procee~ ¢an be c~rried out by treatment with a reducing agent such as hydro~en iodide or catalytic~lly activated hydrogen (e.~. pall~dium in alcohol) or with zinc and glacial acetic acid or amal~mated zinc and sodium hydroxide When Xl represents a hydroxy group, the compound o~ ~ormula IV i~ reacted with 1--phenyl-5-chlorotetrazole and the resulting 1-phenyltetrazol-5-... . .
,................................................ . . .

7~
~yl eth~r is hydrogenated over palladium on carbon. Alternat-ively, the compound of formula IV is first reacted with cyanogen bromide in the presence of triethylamine and the reaction product hydrogenated over palladium on carbon.

Embodiment (c) provides compounds of formula I in which n stands for zero, Z represents an amino, pyrrolo, pyrrolidino, piperidino, -NHR4, -N(R4)2, -NHR5, -NR4CooR4, -N(R4)(R5)~
-NHCooR4~ NHCoNHR3, -NHCSNHR3 or -NR3NH2 group and Rl, R27 R3, R4 and R5 have the significance Kiven earlier.

The di~zotisation of a compound of formuJ~ I in which Z
repre~ents ~n amino grou~ in accordance with embodiment (d) of the present process can be carried out in a manner known per se n i t~o~,$
using ni~;P~-acid or a nitrite and acid. Aqueous hydrochloric acid can be used as the solvent for this diazotisationO ~he resulting diazo~ium salt is then reacted, expediently without isolation, with sodium azide to give a compound of formula I
in which Z represents a -N3 group~ or with an amine of the ~ormula NE(R4)2 to give a compound Or formula I in which Z
.

represents a ~N=N-N(R4)2 group, or with an alkali sulphite to give a compound of formula I in which Z represents a -N~I NH2 group.

Embodiment (e) of the present process can be carried out in a manner analogous to that described in the preceding para-graph for the diazotisation and ylelds compounds of rormula I
in which Z rapresentq a -N(No)R4 group.

~37~
Examples of groups d~noted by ~2 which are convertible b~ reduction into an amino group in accordance with embodiment (f) of the process are nitro~ carbobenzoxyamino, -NH-NH-aryl and -N=N-~ryl. The reductive conversion of the aforementioned groups into an amino group can be carried out b~ catalytic hydrogenation; for example~ by means of hydrog~n and palladium on carbon in an alcohol (e.gl me-thanol) at 10-50C, preferably at room temperature.

Groups denoted by Z which are convertible by hydrolysis into an amino group or a -NHR4 group are, ~or example, the -NHR5, -N=C~7, -N=C(R7)2, -N=CHoR4, -NHCoo~4, -NR4Coo~4 ~lnd -N(R4)(R5) groups (~7 representing an alkyl, alken~l or aryl group) and the phthalimido group. ~he hydrolysis of the afore-mentioned groups i9 expediently carried out in an acidic medium (e.g. with a~ueous or aqeuous~alcoholic m neral acids such as hydrochloric acid)~ Groups denoted by Z which can be hydro-lysed under alkaline conditions are the -NR4CooR4, -NH~CooR4 and -NHCH0 groups. ~he alkaline hydrolysis can be carried out u~ing aqueous or aqueous alcoholic (methanolic) alkali. The phthalimido group can preferably be converted into an amino group by hydrazinolysis.

l'he groups denoted by Z which are present in the pyrim-idine nucleus are expedien-tly hydrolysable groups such as -the acetylamino or formylamino groups, the phthalimido group or the carbobenzoxyamino group.

Embodiment (f) yields compounds of formula I in which n stands for zero, Z represents an amino or NHR4 group and Rl, R2 and R4 have the significance given earlier.

~3s7~

The alkylation or alkenylation of a compound of formula la in accordance with embodiment (g) o the present process can be carried out using an alkyl halide (e.g. methyl iodide) or an alkenyl halide (e.g. allyl bromide) in the presence of a base (e.g. sodium methylate or sodium hydride). As the solvent there can be used, for example dimethylormamide or dimethyl sulphoxide.
Embodiment (g) yields compounds of formulcl [ in w}licll n stands for ~ero, Z ropresents a -N(R4)(RS) or -NR4CooR4 group and Rl, R2, R4 and R5 have the signific~mco gLvell ourLior.
The starting materials used ln the present process, inso-far as they are not known or insoar as they are not described here-inater, can be prepared in a manner analgous to that described in the Examples hereinafter or according to the methods outlined in the following Table in which Rl, R2, Y and zl have the significance given earlier:

~; ' ' . .

~;~3~4~;
. .~
,. ~o; o a) ~g h ~ rl ~1 ~D o o ~ ~ ~ ~ ~ ~ ,1 ~I ~0 .~ ~ 0 ~a~ p~ 00 U~
h ~ rl ;;t ~D C~ ^ N`
rl Ir\ o rl ~ 0 ~1 ~ O
. r~ rl Lr~
a~
--~ ~~ -- ~-~- ~ ~ w w S ~ ,~ h ~1 ~1 0 ~ ~ rl ~-~ ~ 4 E3 ~ ~ rl ~ h ~17 ,~
O ~ ~d O, l r r~ ~ 7 w t~ ~ rO ~ S g ~7 ~ ~d El w ~ 0 ~
~; 1~l h ,~4 0 c) 1~ ~d ~ w .~ C) .~1 0 O ~) a1 r-l rl ' ~ P~ a ~ P,~c~ p C.) ~7 El ~ ~$ r F I ~ ~ ~r ~ d O
r-l OJ
__ ,__ .

E~ . ~
r 0~
~ \ ~ r ~ ~ O
rc~ ~ r \ /
0 P T ~ ~
~ H ~ ?J

1~
r-l C~i N ~;i .. ._~

rl rl H H H H
.
0h ~ _. .__ .. _ .. __ ., /~

The compounds of formula I can be converted into acid addition salts, especially those which are customary in pharma-ceutical preparations~ by treatment with inorganic acids (eig.
hydrochloric acid7 sulphuric acidl phosphoric acid etc) or organic acids (e.~. formic acid, acetic acid, succinic acid, lactic acid~ citric acid, maleic acid, fumaric acid, tartaric ~cid, methanesulphonic acid, p-toluenesulphonic acid etc).

~ he benzylpyrimidine derivatives provided by the present invention (i.e. the compounds of formula I hereinbefore and their acid addition salts) possess antibacterial acitivity.
They inhibit the bacterial dihydrofolate reductase and potent-iate the ~ntibacterial acitivity of ~ul~phonamides such as, for example, sulphisoxazole, sulphadimethoxine, sulphamethoxazole, 4-sulphanilamido-5,6-dimethoxy-pyrimidine, 2 sulphanilamido--4~ 5-dimethyl-pyrimidine, sulphaquinoxaline, sulphadiazine, sulphamonomethoxine, 2-sulphanilamido-4,5-dimethyl-isoxazole and other inhibitors for enzymes which are involved in the folic acid bios~nthesis such as, for example, pteridine deriv-atives.

A combination of one or more of the benzylpyrimidine derivatives aforesaid with sulphonamides can be used in human medicire in a form adapted for oral, rectal or parenteral administration. The ratio of a compound of formula I to a sulphonamide can vary within a wide range; for example, between 1:40 (parts by weight) and 5:1 (parts by weight), the preferred ratio bein~ between 1:1 and 1:5.

? ~ ~

~3~
Thus, for example, a tablet can contain 80 mg of a compound of formula I and 400 mg of sulphamethoxazole, a tablet for children can contain 20 mg of a compound of formula I and 100 mg of sulphamethoxazole and a syrup (per 5 ml) can contain 400 mg of a compound of formula I and 200 mg of sulphamethoxazole.

The compounds of formula I possess a high antibacterial acitivity or a pronounced synergistic effect in combination with sulphonamides. They also have a good compatibility.

. I s ~L~3~'7~ ~

~he ~ollowing Examples illustrate the process provided by the invention:

Example 1 A solution o~ 1~16 g of sodium in 300 ml of absolute ethanol was treated with 9.1 g Or guanidine carbonate and 5.9 g of 4'-(3-anilino-2-cyano-allyl)-2',6'-dimethoxy-acetanilide and boiled under relfux ~or 18 hours. The mixture was diluted with 100 ml of water and the alcohol removed in vacuo. The precip-itated ~-(2,1~-diamino-5-pyrimidinyl)-2',6'~dimethoxy~p-~ce-to-toluidide was filtered of~ under ~uction, washed w.ith water and recry~talli.sed ~rom methanol/ethyl acetate; melting point 278-~279~-~he starting material was prepared as follows:

A solution of 3105 g o~ 4-acet~mido-~,5-dimethoxy-toluene in 2 litres of pyridine/water (1:1) was tre~ted portionwise with 142 g of pota~sium permanganate during 30 minutes while stirring at 80Co ~he mixture was boiled under reflux ~or 1.5 hours.
The manganese dioxide was filtered of~ under suction and washed with 500 ml of hot water. ~e filtrate was evaporated to dry-ness in vacuo at 60C and the residue was dissolved in 200 ml of water. The resulting solution was treated with 2-N sodium hydroxide up to a strongly alkaline reaction and then ext;racted with two 500 ml portions of ethyl acetate. The ethyl acetate extracts were rejected and the aqueous solution was ad~usted to pH 1 with concentrated hydrochloric acidO The precipitated 4-acetamido-3~5-dimethoxy-benzoic acid was ~iltered off under . ............. . .

1L7~
suction, washed with water and recrystallised from methanol~
ethyl acetate; melting point 237-238C~

A solution of 20.4 g of 4-acetamido-3,5-dimethoxy-benzoic acid in 500 ml of abaolute methanol was saturated with dry hydrogen chlorida. After standing ~or 18 hours at room temp-erature, the ~olvent was removed in vacuo. ~he residue was treated with ice-water ~nd with 2-N sodium hydroxide up to a strongly alkaline reaction. The resulting emulsion was extracted with two 500 ml portions of ethyl acetate. ~he ethyl acetate extracts were washed with two 200 ml portions Or water, combined, dried over magnesium sulphate and evaporated to dryness in vacuo.
The residue was dissolved in ~00 ml of absolute tetrahydrofuran.
'rhe solution was treated with 40 ml o~ absolute pyridine and 40 ml of acetic anhydride, stirred for 20 hours at room -temper-ature and subsequently evaporated to dryness in vacuo. The residue was tre~ted with 300 ml of water and extracted with two 600 ml portio~s of ethyl acetate. The ethyl acetate extracts were washed with two 200 ml portions of water, combined, dried over magnesium sulphate and evaporated to dryness in vacuo.
The remaining 4-acet~ido-3~5-dimethoxy-benzoic acid methyl ester was recry tallised from ethyl acetate; melting point 183-184~C.

A suspe~sion of 30.1 g of dimethylsulphone and 11.5 g of sodium hydride (5~/o dispersion in oil) in ~0 ml of dimethyl sulphoxide w~s stirred at 50C for 3 hours with the exclusion f moisture. ~hen, 20.3 g of 4-acetamido-3,5-dimethoxy-benzoic acid methyl ester were added and the mixture was stirred at room temperature for 20 hours. The solution was diluted wi-th 1 litre of water and extracted with three 1 litre portions of 'i '~. ?~

", . . .

~37~
eth~l acetate~ The ethyl acetate extracts were wa~hed with two 300 ml portions of water, combined~ dried over magnesium sulphate ~nd evaporated to dryness in vacuo~ Recrystallisation of the residue from ethyl acetate gave 2',6'-dimethoxy-4'-5 -(methylsulphonyl-acetyl)-acetanilide of melting point 206--207C.

A suspension of 10.1 g of 2',6'-dimethoxy-4'-(methyl-sulphonyl-acetyl)-acetanilide and 4.85 g of sodium borohydride in 400 ml of ethanol was stirred at room temperature for 18 hours. The solution was treated with 100 ml of water and the alcohol was removed in vacuo. The precipitated 4'~ hydro.xy-
-2-methylsulphonyl-ethyl)-2',6'-dimethoxy~ace-tan.i.lide was filt-ered off under suction and recrystallised ~rom methano:L/ethyl acetate; melting point 193-195C.

A mixture Or ~.78 g of sodium methylate, 5.1 g of ~--anilino-propionitrile and 9.8 g of 4'-(1-hydroxy-2-methyl-sulphonyl-ethyl)-2',6'-dimethoxy-acetanilide in 40 ml of dime-thyl sulphoxide was stirred at 50C for 4 hours with the exclusion of moisture~ The mixture was poured into 400 ml of water and the resulting emulsion was extracted with three 500 ml portions of ethyl acetateO The ethyl acetate extracts were washed with two 200 ml portions of water, combined, dried over magnesium sulpha-te and evaporated in vacuo. Recrystallisation of -the residue from ethyl acetate gave 4'-(3-anilino-2-cyano-allyl)-2',6'-dime~hoxy--acetanilide of melting poi.nt 165-167C.

1~ .

~, ....

~ E ~mple 2 .
A solution of 10~1 g of ~ (2~4-diamino-5-pyrimidinyl)--2'~6'-dimethoxy-p acetotoluidide in 600 ml of l-N hydrochloric acid was boiled under reflux for 5 hours and subsequently evap-orated to drynes~ in vacuo. The residue was recrystallised frommethanol/ethanol and yielded 2,4-diAmino-5-(4-amino-3,5--dimethoxy-benzyl)-pyrimidine dihydrochloride of melting point 286C (decomposition)~

Example ~

A solution of 1.3~ g of sodium in 300 ml of absoLllte ethanol was treated with 10~8 K Of Kuanidine carbonate ~md 7.5 g of 4'-(3-anilino-2-cyano-allyl)-2',6'-dimethoxy-N-methyl--acetanilide and boiled under reflux for 20 hours. The alcohol was removed in vacuo and the residue taken up in a mixture of 100 ml of water and 20 ml of ethyl acetate. After stirring at room temperature for 1 hour1 the precipitated ~-(294-diamino--5-pyrimidinyl)-2',6'-dimethoxy-N-methyl-p-acetotoluidide was filtered off under suction, washed with water, dried and recry-stallised from methanol/ethyl acetate; melting point 262-264C.

The starting material was prepared as follows:

A suspension Or 12.0 g of sodium hydride (5~/o dispersLon in oil) in 50 ml of absolute dimethylformamide was treated with a solution of 46.0 g of 4-acetamido-3,5-dimethoxy--toluene in 200 ml of absolu-te dimethylformamide during 30 minutes Imder stirring and exclusion of moisture. After stirrin~ at room . ~ .

~g93747~ f temperature for 4 hours, 31.2 ml of methyl iodide were added dropwise during 20 minutes under stirring and ice-coolingO The mixture was stirred at room temperature for 70 hours and subsequently evaporated to dryness in vacuo9 ~he residue was treated with 300 ml of water and the resulting suspension was with extracted/two 500 ml portions of ethyl acetate. The combined ethyl acetate extracts were washed with 300 ml of water, dried over magne~ium sulphate, filtered and evaporated in vacuo.
Recrystallisatior. of the residue from ethyl acet~te gave 3,5 -dimethoxy-4-(N-methyl-acetamido)-toluene of melting ~oint 160-161Co A solution of ~20l~ g of 3,5 dimetho~y~ (N-mei;hyl-ncel;arn~do)--toluene in 2 litres of pyridine/w~ter (1:1) W~lS treated portion-wise with L80 g of potassium permanganate during 1 hour while stirring at 80C. ~he mixture was boiled under reflux for 1 hour. ~he manganese dioxide was filtered off ~der suc-tion and washed with 1 litre of hot water. ~he filtrate was evaporated to dryness in vacuo. ~he residue was dissolved in 500 ml of water and the resulting solution was extracted with 250 ml of ethyl acetate. ~he ethyl acetate extract was rejected and the aqueous phase treated with concentrated hydrochloric acid up to a strongly acidic reaction~ The precipitated 3,5-dimethoxy-4--(N-methyl-acetamido)-benzoic acid was filtered off under suction, washed with water and recrystallised from methanol; melting point 293~-295C.

suspension of 35.8 g of 3,5-dimethoxy-L~-(N-methyl-~cetamido)-benzoic acid in 500 ml o~ absolute methanol was saturated with dry hydrogen chloride, a solution gradually : 1 , . . .

.

7~7~i occurring~ ~fter standing at room temperature for 20 hours, the solution was evaporated to dryness in vacuo. The residue was treated with 200 ml of ice-water and with a concentrated sodium hydroxide solution up to a strongly alk~line reaction and the resulting emulsion was extracted with two 500 ml portions of eth~l acetate. The ethyl scetate extracts were washed with two 100 ml portions of water, combined, dried over magnesium sulphate, filtered and evaporated in vacuoO After recrystal-lisation from ethyl acetate/cyclohexane, the residue yielded
3~5-dimethoxy-4-(N-methyl-acetamido)-benzoic acld methyl ester of melting point 115-116C.

A suspension Or 35.7 K Of dlmethylsulphone and 1,?.0 ~ Or sodium hydride (5~/o disperc3ion in oil) in 100 ~1 of` abc;oLIlt;e dimethyl sulphoxide wa~ stirred at 50C for 3 hours with the exclusion of moisture and subsequently treated with 34-0 g of 3,5-dimethoxy-4-(N-methyl-acetamido)-benzoic acid methyl ester.
After stirring at room temperature for 2.25 hours, the mixture was diluted with 1 litre of water ~he resulting solution was made acidic with 3-N hydrochloric acid and extracted with two 1 litre portions of ethyl acetate. The ethyl acetate extracts were washed with ~wo 200 ml portions of water, combined, dried over magnesium sulphate and evaporated in vacuo. Recrystallisa-tion of the residue from ethyl acetate gave 2't6'-dimethoxy-N--methyl-4'-(methylsulphonyl-acetyl~-acetanilide of melting point 141-142C.

A suspension of 20.9 g of 2',6'-dimethoxy-N-methyl-~'--(methylsulphonyl-acetyl)-acetanilide and 9.5 g of sodium boro-hydride in 300 ml of ethanol was stirred at room temperature ..

7~
for 20 noursO The solution was diluted with 300 ml of water and the alcohol removed i~ vacuoa ~he resulting suspension was extracted with two 1 litre portions of ethyl acetate. ~he ethyl acetate extracts were washed with two 200 ml portions of water, combined, dried o~er magnesium ~ulphate and evaporated in vacuo. Recry~tAllisation of the residue from ethyl acetate gave 4'-(1-hydroxy-2-methylsulphonyl-eth~1)-2',6'-dimethoxy--N-methyl-acetanilide of melting poi~t 175-177C.

A mixture of 302L~ g of sodium methylate, 8~75 g of ~--~nilino-propionitrile and 14c9 g o~ 4'~ hgdroxy-2-methyl-sulphonyl-ethyl)-2',6'-dlmethoxy-N-methyl-acetE~ilide in 60 ml of absolute dimethyl sulpho~ide was stirred at 50C for 4 hours with the exclu~ion of moisture. ~he solution was poured into 600 ml of water ~nd the resulting emulsion was extracted with two 400 ml portions of ethyl acetate. ~he ethyl acetate extracts were washed with kwo 150 ml portions of water, combined, dried over magnesium sulphate and evaporated in vacuo. Xecrystallisa-tion of the residue from ethyl acetate gave 4'-(3-anilino-2--cyano-allyl~-2'~6'-dimethoxy-N-methyl-acetanilide of melting poi~t 202-2~4C.

Example 4 A solution of 6.9 g of qodium in 1 litre of absolute ethanol was treated with 54 K Of guanldine carbonate and ~1.0 g of 4-amino-x~ ilino-methylene)-3,5-dimethoxy-hydrocinnamic acid nitrile and boiled under re~lux for 20 hoursO 500 ml of water were added and the alcohol was removed in vacuo. ~fter standing at room temperature ~or 2 hours, the crystallised 2,4--diamino-5-(4-amino-3,5-dimethoxy-benzyl)-pyrimidine was t~

:

~3~47~i filtered off under suction~ washed wi-th water and recrystal-lised from methanol; melting point 215 216C~

The starting material was prepared as follows:

13.8 g of sodium were dissolved in 900 ml of methanol.
To this solution were added 46.8 g of 3-hydroxy-5-keto-3--cyclohexene-carboxylic acid. This mixture was stirred, held between -4~C and -8C by means of a cooling bath and treated during 30 minutes with a phenyl-diazonium chloride solution [prepared from 27.9 g of aniline, 450 ml o~ water, 72 ml of concentrated hy~rochloric acid and 2100 g of sodium nitrlte in 90 ml of water~. The resulting mixture wa~ stirr~d ~or a further 1 hour at -5C to -10C. ~he deposited, red reaction product was filtered o~ under vacuum and washed with ca 1000 ml of water. There was obtained 3-hydroxy-5-keto-4-phenylazo-3--cyclohexene-carboxylic acid o~ melting point 218C.

60 g of 3-hydroxy-5-keto-4-phenylazo-3-cyclohexene--carboxylic acid, 200 ml of methanol, 1200 ml of benzene and 5 g o~ p-tolue~esulphonic acid were boiled together under reflux on a wat~r separator ~or 18 hours. After cooling~ the solution was washed with 500 ml of a 5% sodium bicarbonate solution9 then washed with water, dried and e~aporated. The residue was dissolved in ethyl acetate and purified on an aluminium oxide column [500 g; activity stage I~o After evaporation o~ the ethyl acetate and recr~stallisation o~ the residue ~rom benzene/
petroleum ether, there was obtained 3-hydrox~-5-keto-~-phen azo-3-cyclohexene-carboxylic acid methyl ester as a solid of melting point 1l~C~

~ 3 ~3~
54~8 g o~ 3-hydroxy-5~keto-4~phenylazo-3-cyclohexene--carboxylic acid methyl ester~ 12~0 g of acetamide and 2.0 ~
of bromosuccinimid~ were stirred in 600 ml of chloro~orm ~nd treated dropwise with 32.0 g of bromine in 400 ml of chloroform [the reaction temperature being held below 35C~. The separa-tion of acetamide hydrobromide 800n beganO ~he mixture wa5 stirred for a further 30 minutes at room temperature9 the acetamide hydrobromide filtered off and the filtrate evaporated to dryness. The residue was taken up in a small amount of eth~ol, filtered off under vacuum and washed with ethanol.
There was obtained 3,5-dihydroxy~4~phenylazo benzoic acid meth~l es-ter of melting point 216-218C.

A mixture of 27~2 g of 3,5-dihydroxy~ phenylazo-benzoic acid methyl ester, 150 ml of methanol and 64 g of dimethyl sulphate w~s treated during 45 minutes with a solution of 23 K
of sodium hydroxide in 50 ml of water while stirring. Care was taken that the temperature did not exceed 55C by means of a cooling bath. The mixture was stirred at room temperature for a further 1 hour9 cooled with ice-watert filtered off under vacuum and recrystallised from 400 ml of ethanol. Red crystals of 3 9 5-dimetho~y-4-phenylazo~benzoic acid methyl ester were obtained; melting point 130-132C.

12 g of 3~5-dimethoxy-4-phen~lazo-benzoic acid methyl ester were dissol~ed in 400 ml of ethanol and, after the addi~
tion of 0080 g of palladium on carbon, hydrogenated under atmospheric pressure and at room temperature. With slight warming, 2 moles of hydrogen were taken up durin~ 1.5 hour-.
~he catalyst was filtered off and the filtrate concentrated - 26'_ .
. .

in vacuo. ~he resulting aniline was dis-tilled off with steam~
After cooling, the 4~amino-395-dimethoxy-benzoic acid methyl ester which remained as an aqueous suspension9 was filtered off under vacuum, dried and recrystallised from cyclohexane; melting point 115-116C.

A suspension of 214 g of dimethylsulphone and 78.2 g of sodium hydride (5~/o dispersion in oil) in 400 ml Or absolute dimethyl sulphoxide was stirred at 50C under nitrogen and with exclusion of moisture for 3 hours~ ~he mixture was cooled to 30C, whereu.po~ 137 g of 4-~mino-3,5-dimethoxy-benzoic acid methyl ester were added~ the temperature risin6 to 50C. After stirring under nitrogen and at room temperature for ca 1 hour, the resulting mixture wa~ left to stand for 3 hou~s an~l the dissolved in 2 litre~ of water under addition of ice. q1he solution was ad,justed to pH 6-7 with glacial acetic acid. ~fter stirring under ice-cooling for 1 hour9 the crystallised ~'-~nino--3'~5'-dimethoxy-2-methylsulphonyl-acetophenone was filtered off under suction, washed with wa-ter, dried and recrystallised from ethyl acetate; melting point 166-167C.

~ suspension of 123 g of 4'-amino-3',5'-dimethoxy-2--methylsulphonyl-acetophenone and 68 g of sodium borohydride in 1J5 litres of alcohol was sti`rred at room temperature for 20 hours. The suspension was diluted with 1.5 litres of water.
~he alcohol was evaporated in vacuo and the resulting 4-amino--3,5-dimethoxy-~-(methylsulphonyl-methyl)-benzyl alcohol was filtered off under suction, washed with water and dried; meltin~
point 178-179C.

_,~_ ~;33~9~7~
A mixturs of 8.64 g o~ sodium methylate, 1406 g of B--anilino-propionitrile ~nd 22.0 g of 4-amino-395-dimethoxy-~--(methylsulphonyl-methyl)-benzyl alcohol in 50 ml of absolute dimethyl sulphoxid~ was stirred at 50C for 1 hour under nitro~en and with the exclusion of moisture. ~he solution was poured into 500 ml Or ice-water and the resulting emulsion was extracted with two 50~ ml portions of ethyl acetate. The ethyl acetate extracts were washed with two 250 ml portions of water, drled over mag-nesium sulphate and evaporated in vacuo. The residue was dissolved in 60 ml of ethyl acetate. After standing at room temperature for 20 hours, the crystallised 4-amino-a-(anilino--methylene)-3,5-dimethoxy-hydrocinnamic acid nitrile was filt-ered of~ under suction, washed with a small amount Or ethyl acetate and dried; melting point 150-151 A solution of 360 mg of sodium in 100 ml of absolute ethanol was treated with 2.8 g of guanidine carbonate and 2.0 g of 4-(3 anilino-2-cyano-allyl)-2,6-dimethoxy-carbanilic acid ethyl ester and boiled under reflux ~or 20 hours. The solution was diluted with 100 ml of water and the alcohol removed in vacuo. After standing at room temperature ~or 1 hour, the precipitate was filtered off under suction, washed with water and dissolved in ca 2U0 ml of boiling ethanol. The solution was chromatographed on 100 g Or silica gel (Merck~ usin~
ethanol/ethyl acetate (1:1). There was obtained 4-[(2,4-diamino--5-pyrimidinyl)-methylJ-2,6-dimethoxy-carbanilic acid ethyl ester which, a~ter recrystallisation from ethanol, had a melt-ing point of 228C (decomposition).

' : ' '. ' ',...................... ' ~3~7~
~he starting material was prepared as follows:
' A solution (cooled to 0C) of 12~0 g of 4'-amino-3'95'--dimethoxy~2-methylsulpho~yl-acetophenone in 100 ml of absolute pyridine was treated with 5.06 ml of chloroformic acid ethyl ester while stirrirlg. After stirring at room temperature for 20 hours7 the p~ridine wa~ removed in vacuo and the residue t~ken up in 100 ml of water. ~he precipitated 2,6-dimethox~-4-~methylsulphonyl-acetyl)-carbanilic acid ethyl ester was filtered off under suction, washed with water and recrystallised from ethanol; melting point 192 193C.

A su~penslon of 1201 g Or 2,6-dilllethO~-~-(meth;y.lSUlphOn,yl--acetyl)-carbanilic acid eth~l e~ter ~nd 5.~ g of sodium boro-hydride in 150 ml of ethanol was stirred at room temperature for 70 hours. The alcohol was evaporated in vacuo and the residue treated with 150 ml of waterO After standing at room temperature for 1 hour, the cry~tallised 4-(1-hydroxy-2-methylsulphonyl--ethyl) 2~6-dimethoxy-carbanilic acid eth~l ester was filtered off under suction~ washed with ~ter and recrystallised from ethanol; melting point 168-170C.

A mixture of 4042 g of sodium ethylate, 5.1 g of ~-anilino--propionitrile and 10.0 g of 4-(1-hydroxy-2-methylsulPhonyl--ethyl)-2,6-dimethoxy-carbanilic acid ethyl ester in 150 ml of dimethyl sulphoxide was stirred at 50C for 2 hol~s with the exclusion of moisture. The solution was poured into 1.5 litres of water and the resulting emulsion extracted with two 1 litre portions of ethyl acetate. 'rhe ethyl ace-tate extracts were washed with two 500 ml portions of water, combined, dried over magnesium sulphate and evaporated in vacuo~ 'rhe residue was c~ ~ .

g~3~
chromatographed on 800 g of silica gel (Merck~ using methylene chloride/ethyl acetate (3:1). There was obtained 4 (3-anilino--2-cyano-allyl)-2,6 dimethoxy-c~rbanilic acid ethyl ester of melting point 150-151C (recrystallisatlon from alcohol).
., .

~

,, .
A suspension of 1.04 g of 4-[(2~4-diamino-5-pyrimidinyl)--me-thyl]-2,6-dimethoxy-carbanilic acid ethyl ester in a mixture - of 50 ml of 4-N sodium hydroxide and 50 ml of ethanol was boiled under reflux for 18 hours, a solution gradually resulting. ~he alcohol was removed in vacuo. After stand~n~ at rourn temperatllre for 1 hour, the crystalli~ed 2,4-diamino-5-(4-amino-~,5--dimethoxy-benzyl)-pyrimidine w~s filtered of`f under suction~
washed with water and recrystallised from methanol; melting point 215 216C.

~ E~ Z

A solution of 0.1 g of mercury (II) chloride in 2 ml of water and 1.5 g Or zinc powder was added to a solution of 1.5 g of 2~4-diamino-5-(4-amino-3,5-dimethoxy-benzyl)-6-chlorop~yrimidine in 15.5 ml of glacial acetic acid and the mixture was boiled under reflux with stirring overnight. ~'hen, the mixture was filtered while hot, the zinc powder washed with 5 ml of acetic acid and the combined fll-trates added dropwise with stirring at a temperature below 20C, to 1~0 ml of concentrated ammoniaO ~he mixture was stirred at 20C for a further hour and the solid material was filtered off under vacuum, washed with water, dried and recrystallised from methanol. ~here was obtained 2,4-.. . .

~7~L7~i -diamino-5-(4-amino 3 9 5-dimethoxy-benzyl)-pyrimidine of mel-ting point 214C~
., ~he starting material was prepared as follows:
.
138 g of 4-amino-3,~-dimethoxy-~-(methylsulphonyl-methyl)--benzyl alcohol in 250 ml of dimethyl sulphoxide were treated with 9~75 g of sodium amide. The mixture was stirred at room temperature for 1~25 hours and then poured into 2 litres of water. The resulting precipitate was extracted with 2 litres of ethyl acetate and the aqueous phase was extracted with 2 litres of ethyl acetate. ~he combined ethyl acetate phases were washed with two 1 litrc portions O:e deionised wa~er, dried over magnesium sulphate, filtered and evaporated to dryness in vacuo at 40C. ~he crystalline residue was dissolved in 250 ml of hot methanol and the solution treated with 150 ml of water and left to stand at 4C for 18 hours. The crystallised 4--amino-3,5-dimethoxy-benzaldehyde was filtered off under suction9 washed with a mixture of 40 ml of methanol and 20 ml of deionised water and dried in vacuo at 50C; melting point 90-93C.

A mixture of 18~1 g of 4-amino-3,5-dimethoxy-benzaldehyde~
11.3 g of cyanoacetic acid ethyl ester and 3 drops of piperidine was heated at 120C for 1 hour in an open vessel, by which means the resulting water escaped. ~he residue was recrystallised ~rom ethyl acetate/pet~oleum ether. ~here was obtained l~-amino--a-cyano-3,5-dimethoxy-cinnamic acid ethyl ester of melting point 134-136C.

" ' - .:

13 a8 g of 4-amino-a cyano-3,5-dimethoxy-cinnamic acid ethyl ester were hydrogenated in 500 ml of ethanol in the presence of 3 g of palladium on carbon at room temperature and a pressure of 1 atmosphere. After the uptake of the theoretical amount of hydrogen, the reaction was stopped~ The catalyst was separated, the ~iltrate evaporated in vacuo and the residue purified by chromatographyO There were obtained 10.8 g of
4-amino-~-cyano-3,5-dimethoxy-hydrocinnamic acid ethyl ester of melting point 77-78C (recrystallisation from ethyl acetate/
petroleum ether).

13.9 g of 4~amino-~-cyano-3,5-dimethox~ hydrocinnamic acid ethyl ester and a ~uanidine ~olution (pr~p~red from 1.15 g of 30dium in 50 ml of ethanol and 5 g of guanidine hydrochloride) were added to a solution of 1015 g of sodium in 50 ml of ethanol.
The mixture was stirred under reflux for 1 hour and evaporated to dryness. The residue was dissolved in a small amount of water and the solution was filtered, made slightly acidic with acetic acid and then made alkaline with sodium bicarbonate. The precipitat0d 256-diamino-5-(4-amino-3,5-dimethoxy-benzyl)-4--pyrimidinol was filtered off under vacuum and recrystallised from ethanol/water; melting point 267-269C.

2.5 g of dime-thylaniline were added dropwise to a suspension of 2.9 g of 2,6-diamino-5-(4-amino-3,5-dimethoxy-benzyl)-4--pyrimidinol in 15 ml of phosphorus oxychloride while stirring.
The mixture was then brought to boiling during 1 hour and boiled under reflux for 4 hours. 8 to 9 ml of phosphorus oxychloride were distilled off under reduced pressure and the residue was poured on to 80 g of ice while stirring. The mixture was left to st~nd at room temperature for 6 days and then 35 ml of conc-~ ~ 3 ~

entrated ammonia were added portionwise. After standin~ for 2 k hours, the solid material was filtered off lmder vacuum, dried and recrystallised from dimethylform~nide/ether. r~here WRS
obtained 2,4-diamino-5-(4-amino-3 9 5-dimethoxy-benzyl)-6-chloro-pyrimidine of melting point 222-224Co ample 8 A solution of 0.53 g of sodium in 36 ml of absolute ethanol was treated with 2.16 g of guanidine hydrochloride and 3.4 g of ~-(anilino-methylene)-3,5-dimethoxy l~-(pyrrol-l-yl)--hydrocinnamic acid nitrile and boiled for 20 hourt3 Imder nit-rogen while stirring. '~he ethanol W~fi re~moved under re(lllc(!d pressure and the residue taken up in wate~rl ~illered off under v8CUUm~ washed with water and recrystallised from ethanol. There was obtained 2~4-diamino-5-[3~5-dimethoxy-4-(pyrrol-l-yl)-beny~;
-pyrimidine Or melting point 220C.

'rhe starting material was prepared as follows:

A mixture of 9 g of diethoxy-tetrahydrofuran and 5 ml of glacial acetic acid was added dropwise at room temperature to a solution of lOo 5 g of 4-amino-3j5-dimethoxy-benzoic acid methyl ester in 50 ml of glacial acetic acid while stirring. The mixture was stirred at 100C for a further 30 minutes, cooled with ice, filtered off undex vacullm, drled and recrystaLlic;ed from cyclohexane. r1'here was ob-tained ~rj-dimethoxy-~-(pyrrol 1--yl)-benzoic acid methyl ester of mel-ting point 1~5-146C.

A suspension of 2.9 g of sodium hydride (5~o dispersion in oil) and ~o8 g of dimethylsulphone in 20 rnl of absolute dimethyl `' ~3 _ ~ _ . .~

~, , . . ~ , , , ~L~37~
sulphoxide was stirred at 50C for 2 hours under nitrogen and with the exclusion of moisture~ ~hen, the heating was stopped and 5.2 g of 3,5-dimethoxy~4-(pyrrol-1-yl)-benzoic acid methyl cster wero added, the temperature rising to 67C~ ~he mixture was stirred ~or a ~urther 2 hours and dilut~d with 200 ml of ice-water. ~hc a~ueou~ solution w~s sh~ken out with 50 ml of ethyl acetate, filtered over carbon, made acidic with glacial acetic acid and left to ~tand overnight in a refrigerator. The precipitated 3',5'-dimethoxy-2-methylsulphonyl-4'-(pyrrol-1-yl3--acetoph0none was recrystallised from ethyl acetate/petroleum ether; melting point 180C.

A suapension o~ 1.54 g of 3',5'-dimethoxy-2-methylsulphonyl--4'-(pyrrol-1-yl)-acetophenone in 20 ml of ethanol and 20 mL of water wa~ treated with a ~olution of 0./~ g o~ ~odiurn borohydri(3e in 5 ml of water with addition of 0~1 g o~ sodium hydroxide. The mixture was stirred at room temperature for a further 3 hours, cooled with ice, diluted with 50 ml of water and filtered off under vacuum. A~ter recrystallisa-tion from ethanol, there was obtained 3,5-dimethoxy-~-(methylsulphonyl-methyl)-4-(pyrrol-1--yl)-benzyl alcohol of melting point 192C~

A mixture of 2045 g of sodium methylate, 9.75 g of 3,5--dimethoxy-x-(methylsulphonyl-methyl)-4-(pyrrol-1-yl)-ben%yl alcohol and 6.6 g of ~-anilino-propionitrlle in 75 ml of absolute dimethyl sulphoxide was stirred at room temperature for 1 hour under nitrogen and with the exclusion of mois-ture. Then, the mixture was poured into 250 ml of ice-cold water and extracted with three 200 ml portions of ethyl acetate. The ethyl acetate extract was washed with water, dried and evaporated. After chromatography on aluminium oxide and recrystallisation from i ~. ~ . .

, .

7~
ethanol, there was obtained a-(anilino-methylene)-3,5-dimethoxy--4-(pyrrol-1-yl)-hydrocinnamic acid nitrile of melting point 182~184C~

A solution of 0.53 g of sodium in 36 ml of ethanol was treated with 2016 g of guanidine hydrochloride and 3~2 g of 4-amino-~-(anilino-methylene)-3,5-diethoxy-hydrocinnamic acid nitrile and the mixture boiled for 20 hours under nitrogen while stirring. 'rhe ethanol was removed under reduced pressure and the residue taken up in water, fil-tered o.~f under vacuum, washed with wat0r and recrystallised ~rom methanol '~h~re wa~ ob~a:i.rled 2,~--diamino-5~ ~mino-3,5-d:Letho.~-benY.;yl)~pyr;.m:idlne of`ln~lkir point 200-202C.

q'he starting material was prepared as ~ollows:

A solution of 50 g of sodium hydroxide in 200 ml of water was added dropwise to a mixture of 5494 g of 3,5-dihydroxy-4--phenylazo~benæoic acid methyl ester, 400 ml of methanol and 86 g of diethyl sulphate, while maintaining the temperature between 40C and 45C. ~he mixture was then stirred for 2 hours at room te~perature and e~aporated to dr~nessr The residue was shaken with water and ethyl acetate and the organic phase was separated, washed with a sodium carbonate solution and then with water, dried and evaporated. By chromatographic separation a:nd crystallisation from me-tha.nol, there was obtained 3~5-dieth -4-phenylazo-benzoic aci.d methyl ester of meltin~ point 92(,.

, ~L~3~
6.56 g of ~,5-diethoxy-4-phenylazo-benzoic acid methyl ester were dissolved in 100 ml of ethanol and, after the addi-tion of 0.4 g of palladium on carbon, hydrogenated at atmospheric pressure and at room temperature. With slight warming, 2 moles of hydrogen were t~ken up. ~he catalyst was filtered off and the filtra-t~ concentrated in VACUO- ~he aniline formed was di~tilled off with steAm~ After cooling, the 4-amino~3,5--diethoxy-benzoic acid methyl ester which remained as an agueous suspension was filtered off u~der vacuum, dried and recrystal-lised from cyclohexane; melting point 90-92C.

~ suspension of 3.76 ~ of dimethylsulphone and 2 ~ g of sodium hydride (5~/o dispersion in oil) i.n 20 ml of absol.ute dimethyl sulphoxide wa~ stirred at 50C for 2 hour~ der nitrogen and with the exclusion of moisture. 'rhe heating was stopped and ~78 g of 4-ami.no-3~5-diethoxy-benæoic acid methyl ester were added. ~he mixture was heated to 90C for 1 minute, then stirred at room temperature for 1.5 hours and dilu-ted with 100 ml o~ ice-water The aqueous solution was shaken with 50 ml of ethyl acetate, filtered over carbon, made acidic with glacial acetic acid, filtered o~f under vacuum and the resulting 4'--amino-3',5'-diethoxy-2-methylsulphonyl-acetophenone was recry-stallised from ethyl acetate; melting point 161-163C.

A suspension of 26 g of 4'-amino-3',5'-diethoxy-2-methyl-sulphonyl-acetophenone in 350 ml of ethanol and 350 ml Or wate.r was treated with ~ solution of 7.0 g of sodium borohydride in 90 ml of water, with the addition of` 0.5 g of sodium hydroxideO
The mixture was stirred for 17 hou.rs at room temperatule, cooled with ice, diluted with 500 ml of water and filtered off under vacuum~ After recrystallisation from methanol~ -there was ' ~ -,3~-. . ~ . . .

. ' ' , ' , ;, ~7~
obtained 4-amino-3,5-diethoxy-~-(methylsulphonyl-methyl)-benzyl alcohol of melting point 166-168C.

A mixture of 0~82 g of sodium methylate, 300 g of 4-amino--3,5-diethoxy-x-(methylsulphonyl-methyl)-benzyl alcohol and 2.2 g of ~-anilino-propionitrile in 1205 ml of absolute dimethyl sulphoxide was stirred at 55C u~der nitrogen and with -the exclusion of moisture for 5 hours, poured into 100 ml of water and extracted with three 100 ml portions of ethyl acetateO ~he ethyl acetate extract was washed with water, dried and evaporated.
After chromatography on aluminium oxide and recryst~llisation from ethyl acetate/petroleum ether, there was obtained ~-a~nino ~a-(anilino-methylene)-3,5-diethoxy-hydrocinnamic acid nitrile of melting point 179-181C.

Exam~le 1~0 A solution of 0~26 g of ~odium in 20 ml o~ ethanol was treated with 1.08 g of guanidine hydrochloride and 1~9 g of 2'76'-diallyloxy-4'-(3-anilino-2-cyano-allyl)-acetanilide and boiled under ~itrogen while stirring for 20 hours. The ethanol was removed under reduced pressure and the residue taken up in water9 filt@red off under vacuum, washed with wa-ter and recrystal-lised from methanol/water~ ~here was obtained 2,6-di-allyloxy--~-(2,4-diamino-5-pyrimidinyl)-p-acetotoluidide of melting point 176-177C.

~he starting material was prepared as follows:
~35 !'~ '.' _ ,~-.. ..

A mixture of 27 g of 395-dihydroxy-4-phenylazo-benzoic acid methyl ester, 250 ml of ~lacial acetic acid and 21 g of acetic anhydride was ~tirred at 100C for ~ hours, complete solution occurring. This solution was evaporated to dryness under reduced pressure, the residue taken up in methanol, again ~vaporated to drynes~ and the re~idue recrystallised from dimethylformamide/methanol. There was obtained 3-acetoxy-5--hydroxy-4-phen~l~zo-benzoic acid methyl ester of melting point 162G.

30 g of 3-acetoxy-5-hydroxy-4~phenylazo-benzoic acid methyl e~ter were di~sol~ed in 500 ml of metha~ol and, after the addition o~ 3 g of palladium on carbont hydrogenated at atmospheric pressure and at room temperature. With slight warming, 2 moles of hydrogen were taken up. The catalyst was filtered off and the filtrate concentrated in vacuo. The aniline formed was distilled off with steamr After cooling, the 4-acetamido-3,5-dihydroxy~benzoic acid methyl ester which remained as an aqueous suspension was filtered off under vacuum, dried and recrys-tallised from ethyl acetate/petroleum ether;
melting point 202-20~C~

A mixture of 11.25 g of 4-acetamido-3,5-dihydroxy-benzoic acid methyl ester, 12.1 g of allyl bromide, 15 g of dry potassium carbonate and 100 ml of acetone was boiled and stirred on a reflux condenser for 17 hours. The acetone was removed by distillation, the residue taken up in water/ethyl acetate cmd the organic phase separated, washed with water, dried and evap-orated. After recrystallisation from ethyl acetate/petroleum ether~ there was obtained 4-acetamido-3,5-diallyloxy-benzoic 3~
,` `., ,~

,~ . .

acid methyl ester o~ melting point 135-137C.

A suspension of 3076 g of dimethylsulphone and 2.9 g of sodium hydrid~ (5~/o dispersion in oil) in 20 ml o~ absolute dimethyl sulphoxide was stirred at 50C under nitrogen and with the exclusion of moisture for 2 hours. The heating was stopped and 3.0 g of 4-acetamido-3,5-di~llyloxy-benzoic acid methyl ester were added, the temperature rising to 58C. The mixture was then stirred at room temperature ~or 2 hours and diluted with 200 ml of ice-water. The aqueous solution was extracted : 10 with 50 ml of eth~l acetate, filtered over carbon, made acidic with glacial acetic acid and le~t to stand in a refri~erator for 2 hours~ Th~ precipitated 2',6'-bis(~llyloxy)~ (methyl-sulphonyl-acetyl)-acetanilide was r~crystalli~ed from methanol;
melting point 196-197C.

; 15 A Ruspension of 1.7 g of 2',6'-bis(allyloxy)-4'-(methyl-sulphonyl-acetyl)-acetanilide in 20 ml of ethanol and 20 ml of water waq treated with a solution of 0.40 g of sodium borohydride in 5 ml of water, with addition of 0.1 g of sodium hydroxideO
; The mixture was stirred for ~ hours at room temperature and evaporated to dryness~ The residue was taken up in water~
filtered off under vacuum, dried and recrystallised from ethyl acetat~/petroleum ether. There was obtained 2',6'-bis(allyloxy)--4'~ hydroxy-2-methylsulphonyl-ethyl)-acetanillde o.f melting point 162C.

A mixture of 1.4 g of sodium methylate, 3.75 g of ~--anilino-propionitrile and 6.3 g of 2',6'-bis(allyloxy)-4'--(l-hydroxy-2-methylsulphonyl-ethyl)-acetanilide in 43 ml o~
absolute dimethyl sulphoxid~ was stirred at room temperature ~ ,~7 , .. : ' :

~ 379~
under nitrogen and with the exclusion of moisture for 3 hours, poured into 200 ml of water and extracted with ethyl acetate.
~he sthyl acetate extract was washed with water, dried and evap-oratedr After chromato~raphy on aluminium oxide and recrystal-lisation from ethanol, there was obt~ined 2',6'-bis(allyloxy)--4'-(3-anilino-2-cyano-sllyl)-acetanilide of melting point 176-178C~

Example 11 ' A mixture of ~.5 g of sodium methylate, 21.6 g of guanldine carbonate and 12.~ g of a-(4-amino 3,5-dimethoxy-benzyl)-4--morpholino-acrylonitrile in 120 ml of ab~olute dim0thyl suiphoxide was ~tirred at 120C ror 60 hours. Subsequently, the mixture was diluted with 1.2 litre~ of water and extracted with two 2 litre portions of ethyl acetate~ ~he ethyl acetate extract wa~ washed with two 1 litre portions of water, dried over m~gnesium sulphate and evaporated in vacuo. After recrystal-lisation of the residue from methanol9 there was obtained 2,4--diamino-5-(4-amino-3,5-dimethoxy-benzyl)-pyrimidine of melting point 215-216C.

The starting material w~s prepared as follows:

A mixture of 8.1 g (0.15 mol) of sodium ~ethylate and 2100 g (0.15 mol) of ~-morpholino-propionitrile in 100 ml of ab~olute dimethyl sulphoxide was treated during 10 minutes with a solution of 18.1 g (0.1 mol) of 4-amino-3,5-dimethoxy-benz-aldehyde in 50 ml of absolute dimethyl sulphoxide while stirrin~at 60C. A~ter stirring at 60C for 30 minutes, the mixture was poured into 1.5 litres of water and the precipitate was .

~.~3~t7~
extracted with two 1 litre portions of ethyl acetate. The ethyl acetate extract was washed with two 500 ml portions of water~ dried over ma~nasium sulphate and evaporated in vacuo.
~here wer~ obtained 35 g of crystalline residue which were triturated with 40 ml of alcohol and, after standing for 2 houris at 4C, filtered o~f under suction, washed with a small amount of ice-cold alcohol and driedD ~here was obtained a-(4-amino--3,5-dimethoxy-benzyl)-4-morpholino-acrylonitrile of melting point 128-129C.

_ ample~ 12 A isolution of 1.~ g of sodium in 200 ml of absolute alcohol was treated with 10~3 g of ~uanidine carbonate and 5 g of 4-amino-3,5-dimethoxy-a-(ethoxy-methyl)-cinnamic acid nitrile and boiled under reflux for 48 hours. After the addition of 200 ml Or water, the alcohol was removed in vacuo and the mixture wa~ then extracted with two 500 ml portions of ethyl acetate. The insoluble material was separated and rejected.
The eth~l acetate extract was washed with 200 ml of water, dried over magnesium sulphate and evaporated in vacuo. ~he residue was chromatographed on 90 g of silica gel (Merck) using ethyl acetate/methanol (3:13. There was obtained 2,4-diamino-5-(4-amino-3t5-dime-thoxy-benzyl)-pyrimidine of melting point 215-216C (recrystallisation from methanol).

~he starting material was prepared as follows:

A solution of 4~6 ~ o~ sodium in 400 ml of absolute alcohol wa~ treated with 18.1 g of 4~amino-3,5-dimethoxy-benz-aldehyde and 1908 g of ~ethoxy-propionitrile and boiled under .: ~ . :

7~i reflux for 20 hours~ The mixture was then evaporated to dr~fness in vacuo and the residue dissolved in a mixture of 1.2 litres of ethyl acetate and 300 ml of water with shaking~ After sep-araticn of the phases, the ethyl acetate extract was washed with 300 ml of water9 dried over magnesium sulphate and evaporated to dryness in vacuo. The residue was chromatographed on 1 kg of silica ~el (Merck) using ethyl acetate/methylene chloride (1:9).
There was obtained 4-amino-3~5-dimethoxy-~-(ethoxy-methyl)--cinnamic acid nitrile of melting point 54-55C (recrystallisa-lQ tion from alcohol/water).

A solution of 1.~4 g o~ sodium in 200 ml of absolute alcohol was treated with 14.4 g of guanidine carbonate and 8.9 g of 4'-(3 anilino-2-cyano-allyl)-2',6'-dimethoxy-formanilide and boiled under reflux for 20 hours. Then, 200 ml of water were added and the alcohol was removed in vacuo. After standing at room temperature for 2 hours, the crystals formed were filtered off under suction, washed with water and recrystallised from methanol. ~here was obtained 2,4-diamino-5-(4-amino-3,5--dimetho~y-benzyl)-pyrimidine of melting point 215-216C.

The starting material was prepared as follows:

~ solution (cooled to 10C) of 18.1 ~ (0.1 mol) of 4-amino--3,5-dimethoxy-benzaldehyde in 210 ml of 98~' ~ormic acid was treated dropwise with 70 ml of acetic anhydride while stirring and maintaining the temperature below 15C~ The solution wa5 then stirred for 2 hours at room temperature, treated with 80 ml of water and evaporated to dryness in vacuo7 The residue was 7~i washed with water and recrysta.llised from alcohol. There was obtained 2'96'-dimethoxy-4'-formyl-formani.lide of meltin~ point 159-160C.

A mixture of 2~7 g of sodium methylate, 3.. 65 g of ~-anilino--propionitrile and 1~ o 2 g of 2',6'-dimethoxy-LL'-formyl-formanilide in 30 ml of absolute dimethyl sulphoxide was stirred at 50C for 30 minutes. 'rhe solution was poured into 500 ml of water and the resulting emulsion extracted with two 500 ml portions of ethyl acetate. The ethyl acetate extract was washed wi.th two 300 ml portions of water, dried over magne~ium sulphate and evap-orated in vacuo. ~he residue wa~ recrystall:~s~d from ethyl acetate.. ~here was o'bta.ined l~'-(3-ani:Lillo-2-cy~no-all~yl)-2',6'--dimethoxy-formanilide of meltin~ point 186-187C~

Exemple 14 A solutioIl of 2~75 ~ of 2,4-diamino-5-(4-amino-395--dimethoxy-benzyl)-pyrimidine in 50 ml of methanol was treated with 10 ml o~ l-N hydrochloric acid. The resulting precipitate was dissolved by warming and the solution evaporated at 60C in vacuo to ca 20 mlO After standing at room temperature for 2 hours.
the precipitate was filtered off under suction9 washed with methanol and dried. 'rhere was obtained 2,4-diamino-5-(4-amino--3,5-dimethoxy-benzyl)-pyrlmidi.ne hydrochlor.ide of meltin~; point 296C (decomposition).

A solution of 7 g of 2,4-diamino-5-(4-amino-3,5-dimethoxy--benzyl)-pyrimidine dihydrochloride in 60 ml o:E l-N hydrochlori.c ~/

7~
acid and 40 ml of water was treated durin~ 5 minutes with - stirring and ice-cooling with a solution of 1~52 g of sodium nitrite in 10 ml of water. After stirring at 0C for 30 minutes9 a solution of 1~43 g of sodium azide in 20 ml of water was added~
The solution was stirred at 0C for 2 hours and then treated with soda up to an alkaline reaction. After stirring at 0C for 1 hour, the precipitate was filtered off under suction, washed with water and recrystallised from methanol. There was obtained 2,4--diamino-5-(4-azido-3,5-dimethoxy-benzyl)-pyrimidine of melting point 152C (decomposition).

Example 16 A solutio~ Of 7 K Of 2t~-diamino-5-(4-amino-3,5-dimethoxy--benzyl)-pyrimidine dih~drochloride in 60 ml of l-N hydrochloric acid and 40 ml of water was treated during 5 minutes with stirring and ice-cooling with a solution of 1.52 g of sodium nitrite in 10 ml of water. ~he solution was stirred at 0C ~or 30 minutes and 14.6 g of diethylamine were then addedO After stirrin~ with ice-cooli~g for 2 hours, the precipitate was filtered off under suction, washed with water and recrystallised from methanol.
There was obtained 2,4-diamino-5-[4-(3,3-dieth~ triazino)--3,5-dimethoxy-benæyl]-pyrimidine of melting point 196-197C
(decomposition)0 Example=17 A mixture of 807 g of 4-~(2,4-diamino-5-pyrimidinyl)--methyl~-2,6-dimethoxy-carbanilic acid ethyl ester and 1-L~4 g of sodium hydride (50% dispersion in oil) in 75 ml of absolute dimethylformamide was stirred at room temperature for 1 ho~r - ~ _ ,~ _ 7~
and then treated with 4.26 g of methyl iodide. After stirring at room temperature for 3 hours7 the dimethylformamide was removed at 60C in vacuo and the re~sidue dissolved in a mixture of 500 ml of ethyl acetate and 150 ml of water. After separa-
- 5 tion of the phases, the aqueous phase was extracted with 500 ml of ethyl acetate. ~he cornbined ethyl acetate extracts were washed with 300 ml of water, dried over maKnesium sulphate and evaporated in vacuo. After recrystallisation of the residue from alcohol, there was obtained 4-[(2,4-diamino-5-pyrimidinyl)--methyl]-2~6-dimethoxy-N-methyl-carbanilic acid ethyl ester of melting point 187-188C.

A mixture of 12 g of 4-C(2,4-diamino-5-pyrimidinyl)-methyl~--2,6-dimethoxy-carbanilic acid ethyl ester and 2 g of sodium hydride (5~/o dispersion in oil) in 100 ml of absolute dimethyl-formamide was stirred at room temperature for 4 hours and then treated with 6.5 g of ethyl iodide. After stirring at room temperature for 30 minutes, the dimethylformamide was removed at 60C in vacuoO rrhe residue was taken up in 250 ml of water and the precipitated product extracted with two 600 ml portions o~ ethyl acetate. rrhe ethyl acetate extract was washed with two 300 ml portions of water, dried over magnesium sulphate and evaporated in vacuo. rrhe re5idue was chromato~raphed on ~50 g o~ silica gel (Merck) using ethyl acetate/alcohol (3:1). r~here was obtained N-ethyl-4~[(2,4-diamino-5-pyrimidinyl)-methyl~--2~6~dimethoxy-carbanilic acid ethyl ester of melting point 165-167C (recrystallisation from ethyl acetate)O

' _~_ .

3~
~e~
.
A solution of 414 mg of sodium in 100 ml of absolute alcohol was treated with 3.24 g of guanidine carbonate and 2 g of ~-(anilino-methylene)-4-dimethylamino-3,5-dimethoxy-hydro-cinnamlc acid nitrile and boiled under reflux for 20 hours.
After the addition of 50 ml of water, the alcohol was removed in vacuo. rrhe precipitate was filtered off under suction, washed with water and recrystallised from methanol. There was obtained 2,4-diamino-5-(4-dimethylamino-3,5-dimethoxy-benzyl) -pyrimidine of melting point 218-219C.

'rhe starting material was prepared as follows:
.~
48 g of dimethyl sulphate were added dropwise durin~ 30 minutes while stirring at room temperature to a suspension of 40 g of 4-amino-3,5-dimethoxy-benzoic acid methyl ester and 130 g of anhydrous potassium carbonate in 1.7 litres of anhydrous tetrahydrofuran. The mixture was boiled under reflux for 18 hours while stirring. r~he tetrahydrofuran was evaporated in vacuo and the residue treated with 600 ml of water. The prec-ipitated product was extracted with two 600 ml portions of ethyl acetate and the extract was washed with two 300 ml portions of water, dried over magnesium sulphate and evaporated in vacuo.
rrhe residue was chromatographed on 1.5 kg of silica gel (Merck) usin~ methylene chloride/ethyl acetate (9:1). rrhere was obtained 4-dimethylamino-3,5-dimethoxy-benzoic acid methyl ester of ~5 melting point 71-72C (recrystallisation from cyclohexane).

A suspension of 21.6 g of dime-thylsulphone and 7.7 g of sodium hydride (50Yo dispersion in oil) in 80 ml of absolute , ~ --~

~g~3~
dimethyl sulphoxide was stirred at 50C for 3 hours under nitrogen and with the exclusion of moisture~ The mixture was cooled to 30C and 15.6 g of 4-dimethylamino-3,5-dimethoxy--benzoic acid methyl ester were added. hfter stirring at room temperature for 4 hours, 500 ml of water were added and -the solution was made neutral wi-th glacial acetic acid. ~he prec-ipitate was filtered off under suction, washed with water, dried and recrystallised from ethyl acetate/cyclohexane. ~here was obtained 4'-dimethylamino-3l,5'-dimethoxy-2-methylsulphonyl--acetophenone of melting point 111-112Co A suspension of 24 g of ~'-dimethylam:ino-~',5'-dimethoxy--2-methylsulphonyl-acetophenone and 12~1 ~ of ~odium borohydride in 260 ml of alcohol was stirred at room temperature for 16 hours, a solution resultin~. After the addition of 260 ml of water, the alcohol was evaporated in vacuo. The precipitate was filt-ered oXf under suction, washed with water and recrystallised from ethyl acetate. There was obtained 4-dimethylamino-3,5-dimethoxy--~-(methylsulphonyl-methyl)-benzyl alcohol of melting point ~47~148Co A mixture of 3.3 g of sodium methylate, 8.9 g of ~-anilino--propionitrile and 15.7 g of 4-dimethylamino-3,5-dimethoxy-~--(me-thylsulphonyl-methyl)-benzyl alcohol in 40 ml of absolute dimethyl sulphoxide was stirred at 50C under nitrogen for 2 hours~ ~he mixture was poured into 400 ml of water and the resulting emulsion was extracted with two 400 ml portions of ethyl acetate. 'rhe ethyl acetate extract was washed with two 200 ml portions of water, dried over magnesium sulphate and evaporated in vacuo. AXter recrystallisation of the residue from ethyl acetate, there was obtained ~-(anilino-methylene)-~ .
,~ _.~ _ -4-dimethylamino-3,5-dimethoxy-hydrocinn~nic acid nitrile of melting point 130-1~2C~

A solution of 1.29 g (56 mmol) of sodium in 200 ml o~
absolute alcohol was treated with 10 ~ (56 mmol) of guanidine carbonate and 6 g (18.6 mmol) of a-(anilino-methylene)-3,5--dimethoxy-4-methylamino-hydrocinnamic acid nitr:i.le and boilQd under re~lux ~or 20 hours. Subsequently, 200 ml of water were added and the alcohol was evaporated in vacuo~ .~fter standing at room temperature for 2 hours, the preci.pitat~ was ~:i.l-tered off under suction, washed with water and .recrystallised ~rom alcohol. I`here was obtained 2,4-diamino-5-(3,5-dimethoxy-4--methylamino-benzyl)-pyrimidine of mel-ting poin-t 204C.

~he startin~ material was prepared as follows:

A solution of 5006 g of ~-amino-3,5-dimethoxy-benzoic acid methyl ester in 1 litre of absolute pyridi~e was treated during 30 minutes with 82 g o~ carbobenzoxy chloride while stirring a~d/~ce-coolingO q'he mixture was stirred at room temperature for 20 hours. The pyridine was evaporated in vacuo and the residue treated with 1 litre of water and 3-N hydrochloric acid up to a strongly acidic reaction. q1he result:ing emulsio.n was extracted with two 1.5 litre portions of ethyl aceta-te. I`he ethyl acetate extract was washed with two 800 ml por-tions of water, dried over magnesium sulphate and evaporated in vacuoO
Arter recrystallisation Or the residue rrom ethyl acetate 9 there was obtained 2,6-dimethoxy-4-(methoxy-carbonyl)~carbanilic acid ~03~
benzyl ester of melting point 132-133C, A suspension of 3402 g of 2~6-dimethoxy-4-(methoxy--carbonyl)-carbanilic acid benzyl ester and 5.8 g of sodium hydride ( 5~/a dispersion in oil) in 300 ml of absolute dimethyl-formamide was stirred at room temperature for 4 hours. Theresulting solution was treated with 17 g of methyl iodide while stirring and with ice-cooling. After stirring at room temper-ature for 1 hour, the dimethylformamide was removed in vacuo at 60C. Then, 1 litre Or water was added to t;he residue and the emulsion was extracted with two 2 litre portions Or ethyl acetate. 'rhe organic phaseR were washed with two 1 Litr~e ~ortions of water, dried over magn~sium suLphate and evaporate~d ln VaCllO-After recrystallisation of the residue from alcohol, -there was obtained 2,6-dimethoxy-4-(methoxy-carbonyl)-N-methyl-carbclnilic acid benzyl ester of melting point 1~0 1~1C.

A suspension of 3305 g of 2,6-dimethoxy-4-(methoxy-carbonyl)--N-methyl-carbanilic acid benzyl ester in 1 litre of methanol was hydrogenated in the presence of 105 g of palladium on carbon (5C/o) until the hydrogen uptake stopped. The suspension was heated to boiling and filtered. The filtrate was evaporated in vacuo and the residue recrystallised from cyclohexaneO There was obtained 3,5-dimethoxy-4 methylamino-benzoic acid methyl ester of melting point ~9-51~C.

~ suspension of 44.2 g of dimethylsulphone and 16 g of sodium hydride (5~Yo dispersion in oil) in 150 ml Or absolute dlmethyl sulphoxide was stirred at 50C for 4 hours under nitrogen and with the exclusion of mois-ture. 30.4 g of 3,5-~}`` ~7 7g~
-dimethoxy-4-methyl~mino-benzoic acid methyl ester were added and the mixture was stirred at 80C for 10 minutes and at 25C
for 30 minutes. '~he mixture was then dissolved in 600 ml of water and the solution was made neutral by the addition of glacial acetic acidO The precipitate was filtered off under suction, washed with water, dried and recrystallised from ethyl acetate. ~here was obtained 3',5'-dimethoxy~4'-methylamino-2--methylsulphonyl-acetophenone of melting point 98-99C.

A suspension of 31 g of 3',5'-dimethoxy-L~'-methylamino-2--methylsulphonyl-acetophenone and 16.3 g Or sodium borohydride in 600 ml of ethanol was stirred at room temperature for 16 hoursO
'~he ~olutlon was diluted with 600 ml O.r water and the ~lcohol distilled off in VACUO. ~he crystals formed w~re filtered off under suction, washed with water and dried. ~here was obtained 3,5-dimethoxy-4-methylamino-~~(methylsulphonyl-methyl)-benzyl alcohol of melting point 141-142C.

A mixture of 2.7 g of sodium methylate, 7.3 g of ~-anilino--propionitrile and 12 g of 3,5-dimethoxy-4 methylamino-~-(methyl-sulphonyl-methyl)-benzyl alcohol in 100 ml of absolute dimethyl sulphoxide was stirred at 50C under nitrogen for 30 minutes and then poured into 1 litre of water. The resulting emulsion was extracted with two 1 litre portions of ethyl acetate. The ethyl acetate extract was w~shed with two 500 ml portions of water, dried over magnesium sulphate and evaporated in vacuo. After recrystallisation of the residue from ethyl acetate, there was obtained a-(anilino-methylene)-3~5-dimethoxy-4-methylamino--hydrocinnamic acid nitrile of melting point 150-152C.

~37 . ~

. A solution of 2~9 g of 2,4~diamino-5-(3~5-dimethoxy-4--methylamino-benzyl)-pyrimidine in 40 ml of l-N hydrochloric acid was treated dropwise with a solution of 830 mg of sodium nitrite in 10 ml of water while stirring and with ice-cooling.
The mixture was stirred for 3 hours at room temperature and then sodium carbonate was added up to an alkaline reaction. ~he .. .
precipitate was filtered off under suc-tion, washed with water and recrystallised from methanol. There was obtained 2,4~
-di~mino-5-~3,5-dimethoxy-4-(methyl-nitro~oamino)-benzyll pyrimidine of meltin~ point 249-250C (decomposition)~

Example 22 A solution of 4.3 g of sodium in 1 litre of absolute alcohol was treated with 33.6 g of guanidine carbonate and 21 g f a-(anilino-methylene)-4-ethylamino-3 5-dimethoxy-hydrocinnamic acid nitrile and boiled under reflux for 20 hours. After cooling, 1 litre of water was added and the alcohol was removed in vacuo.
The precipitate was filtered off under suction, washed with water and recrystallised from alcohol. ~here was obtained 2,4-- 20 -diamino-5-(4-ethylamino-3~5-dimethoxy-benzyl)-pyrimidine of melting point 186-188C.

~he starting material was prepared as follows:

A suspension of 103 ~ of 2,6-dimetho~y-4-(methoxy-carbonyl)--carbanilic acid benzyl ester and 17.3 g of sodium hydride (50Yo dispersion in oil) in 1 litre of absolute dimethylformamide was stirred at room temperature for 4 hours and subsequentl~ treated ~3~
.. ~
with 56.2 g of ethyl iodide while stirring and with ice-cooling.
After stirring at room tempera-ture for 30 minutes t the dimethyl-formamide wa~ removed at 60C in vacuo. ~hen, 1 li-tre of water was added to the residue and the mixture was extracted with two 1.5 litre portions of ethyl acetate. The ethyl acetate extract was washed with two 700 ml portions of water, ~ried over magnesium sulphate and evaporated in vacuo. After recrystallisation of the residue from alcohol, there was obtained N-ethyl-2,6--dimethoxy-4-(methoxy-carbonyl)-carbanilic acid benzyl ester of melting polnt 85-86C~

A suspension of 77.5 g of N-ethyl-2,6-dimethoxy-~l-(methoxy--carbonyl)-carbanilic acid benz~l e~ter in 1 litre of methnnol was hydrogenated in the presence Or 2 g of palladium on carbon (5%) until the hydrogen uptake stopped. The suspension was heated to boiling and filtered. '~he filtrate was evaporated in vacuo. After recrystallisation of the residue from cyclohexane, there was obtained 4-ethylamino-3,5-dimethox~-benzoic acid methyl ester of melting point 50-51CD

A suspension of 58~4 g of dimethylsulphone and 21~2 g of sodium hydride (5~/o dispersion in oil) in 200 ml of absolute dimethyl sulphoxide was stirred at 50C under nitrogen and with the exclusion of moisture for l~ hours. 'rhen, 4206 g of 4--ethylamino-3,5-dimethoxy-benzoic acid methyl ester were adcled and the mixture was stirred at 80~C for 10 minutes and subsequent-ly dissolved in 1 litre of water~ 'rhe solution was made neutralwith glacial acetic acid. '~he precipitate was filtered off under suction, wa~hed with water, dried and recrystallised from ethyl acetate. 'rhere was obtained 4'-ethylamino-3',5'-dimethoxy--2-methylsulphonyl-acetophenone of melting ooint 129-130C.

5~
3 -~
t, A suspension Or 48 g of 4' ethylamino-3'95'-dimethoxy--2-methylsulphonyl-acetophenone and 23.8 g of sodium borohydride i in 1 litre of alcohol was stirred at rocm temperature for 20 hours9 a solution resulting. After the addition of 1 litre of water, the alcohol was evaporated in vacuo. ~he crystals formed were filtered off under suction~ washed with water and dried.
There was obtained 4-ethylamino-3,5-dimethoxy~-(methylsulphon~1--methyl)-benzyl alcohol of melting point 121-122C.

A mixture of ~9 g of sodium methylate, 24.1 g of ~--anilino-propionitrile and 41.5 g Or 4-ethylamino-3,5-(iimethoxy--~-(methylsulphonyl-methyl)-benz~l alcohol in 200 ml of' a'bsolute dimethyl sulphoxide was stirred uncler nitro~e~ at 50C for 20 minutes. ~he mixture was poured into 2 litres of water and the resulting emulsion was washed with two 1 litre portions of water9 dried over magnesium sulphate and evaporated in vacuo. After recrystallisation of the residue from ethyl acetate, there was obtained ~-(anilino~methylene)-4-ethylamino-3,5-dimethoxy-hydro-cinnamic acid nitrile of melting point 128-130C.

Example 2~

A solution of 1~95 g of sodium in 500 ml of absolute alcohol was treated with 15.3 g of guanidine carbonate and 9.~ g of 4 amino-~-(anilino-methylene)~3~5-dimethyl-h~drocinnamic acid nitrile and boiled under reflux for 40 hours. 500 ml of water were added and the alcohol was removed in vacuo. The precip-itate was filtered off under suction, washed with water and recrystallised ~rom methanol. ~here was obtained 2,4-diamino--5-(4-amino-395-dimethyl-benzyl)-pyrimidine of melting point 258~260C.

\, ~/

; ~3~76 ~he starting material was prepared as fo]lows:

A suspension of 33 g of dimethylsulphone and 11 g of sodium hydride (5~/o dispersion in oil) in 160 ml of absolute dimethyl sulphoxide was stirred at 50C under nitrogen and with the exclusion of moisture for 3 hoursO '~hen, 18 g of ~-amino-~3,5-dimethyl-benzoic acid methyl ester were added. ~he mixture was stirred at 80C for 30 minutes and at room tempera-ture for 1 hour and then dissolved in 400 ml of water. ~he solution was made neutral with glacial acetic acid and the precipitate fil-tered off under ~uction, washed with water, dried and recrystal-lised from ethyl acetate~ ~here was obtained 4'-~mino-3',5'--dimethyl-2-methylsulphonyl-acetophenone of melting point 179-180C.

A suspension of 16~5 g of 4'-amino-3',5'-dimethyl-2--methylsulphonyl-acetophenone and 10.6 g of sodium borohydride in 500 ml of alcohol was stirred at room temperature for 20 hours~ a solution resulting. After the addition of 500 ml of water~ th~ alcohol was evaporated in vacuo and the mixture extracted with two 1 litre portions of ethyl acetate. The ethyl acetate extract was washed with two 500 ml portions of water, dried over magnesium sulphate and evaporated in ~acuoO
After crystallisation of the residue from ether, there was obtained 4-amino-3,5-dimethyl-~(methylslllphonyl-methyl)-benzyl alcohol of meltin~ point 1~6-148C.

A solution of 14.6 g of 4-amino-3~5-dimethyl-~-(methyl-sulphonyl-methyl)-benzyl alcohol in 50 ml of absolu-te dimethyl sulphoxide was treated with 1.17 g of sodium amide, stirred for ,. . . : . . ,,., , - . .: . . .

~3 2 hours at room temperature, diluted wi-th 500 ml of water and extracted with two 500 ml portions of ethyl acetate. The ethyl acetate extract was washed with two 200 ml portions of water and evaporated in vacuoq After recrystallisation of the residue from cyclohexane, there was obtained 4-amino-3,5-dimethyl-benz-aldehyde of melting point 75-76Cv A mixture of 1.38 g of sodium methylate and 3.8 g of 4-amino~3,5-dimethyl-benzaldehyde in 30 ml of absolute dimethyl sulphoxide was treated under nitrogen during 10 minutes with a solution of 3.72 g of ~-anilino propionitrile in 30 ml of absolute dimethyl sulphoxide while stirring a-t 55C and th~n ~tirred for 1 hour at 700a~ The solution was pollred into 1 litre of water and the resulting emulsion extracted with -two 500 ml portions of ethyl acetateO The ethyl acetate extract was washed with two 300 ml por-tions of water, dried over ma~-nesium sulphate and evaporated to dryness in vacuo. After recrystallisation o~ -the residue from ethyl acetate, there was obtained 4-amino-~-(anilino methylene~-3,5-dimethyl-hydro-cinnamic acid nitrile of melting point 165-167C-~

A solution of 0.69 g of sodium in 100 ml of absolutealcohol was treated with 504 g of guanidine carbona-te and 3 g of ~-(anilino-methylene)-4-dimethylamino-3,5-dimethyl-hydro-cinnamic acid nitrile and boiled under reflux for 20 hours.
200 ml of water were added and the alcohol was evaporated in vacuo. ~he crystals formed were filtered off under suction, washed with water and recrystallised from alcohol. ~here was ., ~r 5e~

.

~D3~
obtained 2,4-diamino-5-(4-dimethylamino-3,5-dimethyl-benzyl)~
-pyrimidine of melting point 162-163C.

The starting material was prepared as follows:

50.4 g (0.4 mol) of dimethyl sulphate were added dropwise during 20 minutes to a suspension of 18 g of 4-amino-3,5--dimethyl-benzoic acid methyl ester and 69 g of potassium carbonate in 1 litre of absolute tetrahydrofuran while stirring at room temperature. The mixture was boiled at reflux for 18 hours while stirring and then filteredO The filtrate was evap-orated to dryness in vacuo. The residue was treated with 500 ml of water and then extracted with two 300 ml portions Or et;hyl acetate. The ethyl ac~tate e~tract was washed with two 150 ml portions of water, dried over magnesium sulphate and evaporated in vacuo. r~he residue was chromatographed on 500 g of silica gel (Merck) using methylene chloride. ~here was obtained 4--dimethylamino-3,5-dimethyl-benzoic acid methyl ester as a colourle2s oilO

A suspension of 240 5 g of dimethylsulphone and 9 1 g of sodium hydride (5~/o dispersion in oil) in 5Q ml of absolute dimeth~l sulphoxide was stirred at 50C under nitrogen and with the exclusion of moisture for 3 hours and then treated with 16 g of 4-dimathylamino~3,5-dimethyl-benzoic acid methyl ester. The mixture WAS stirred at 80C for 45 mi~utes, cooled and dissolved in 300 ml of water. ~he solution was made neutral with ~lacial acetic acid. The precipitate was filtered off under suction, washed with water and recrystallised from alcohol~ ~here was obtained 4'-dimethylamino-3' 9 5'-dimethyl-2-methylsulphonyl-~acetophenone of melting point 132-133C.

A suspension of 12 g of 4'-dimethylamino-3' 9 5'-dimethyl--2-methylsulphonyl-acetophenone and 6.6 g of sodium borohydride in 300 ml of alcohol was stirred at room temperature for 20 hours, a solution resulting. After the addition of 300 ml of water, the alcohol was removed in vacuo. ~he crystal~ formed were filtered off under suction, washed with water and dried.
~here was obtained 4-d.imethylamino-3,5-dimethyl-~-(methyl-sulphonyl-methyl)-benzyl alcohol of melting point 133-134Co A mixture of 1.3 g of sodium methylate, 3.5 g of ~-anilino--propionitrile and 4~8 ~ of 4-dimeth~lamino-3,5~dimeth~1-a--(methylsulphonyl-methyl)-benzyl alcohol iXl 30 ml of a~solute dimethyl sulphoxide was stirred R~ 50C f`or ~0 minutes. ~he solution w~s poured into 1 litre of water and extracted with two 500 ml portions of eth~l acetate. ~he ethyl acetate extract was washed with two 300 ml portions of water, dried over magnesium sulphate and evaporated in vacuo. After recrystallisation of the.re~idue from ethyl acetate, there was obtained ~-(anilino--methylene)-4~dimethylamino-3,5-dlmethyl-hydrocinnamic acid nitrile o~ meltin~ point 195-196C~

S~

- . . ..

~ ~ 3~

Exam~le 25 Tablet ~ormulation:

2,4 diamino-5-(4-amino-~,5~dimethoxy~
benzyl)-pyrimidine-dihydrochloride 101.2 mg SulYamethoxazol~ . 400 mg Corn Starch 142 mg r~alc 5 mg Magne~ium Steara-te 1.8 mg . rl'otal ~ lght650 mg ~ :"
s6~
~~ ~, .. . . . .

Claims (31)

  1. THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
    PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
    l. A process for the manufacture of benzylpyrimidine derivatives of the general formula (I) wherein R1 and R2 each independently represent a C1-3 alkyl, C1-3 alkoxy, C2-3 alkenyl or C2-3 alkenyloxy group, Z represents a nitro, amino, pyrrolo, pyrrolidino, piperidino, -NHR4, -N(R4)2, -NHR5, -N(R4)(R5), -NR4COOR4, -NHCOOR4, -NHCONHR3, -NHCSNHR3, -N3, -N=N-N(R4)2, -N(NO)R4 or -NR3-NH2 group, R4 represents a C1-3 alkyl or C2-3 alkenyl group, R5 represents an acyl group, R3 represents a hydrogen atom or a C1-3 alkyl or C2-3 alkenyl group, A represents an oxygen atom bonded to one of the cyclic nitrogen atoms and n stands for zero or 1, and pharmaceutically acceptable salts thereof, which process comprises a) reacting a compound of the general formula (IIa) (IIb) wherein Z1 represents a nitro, amino, pyrrolo, pyrrolidino, piperidino, -NHR4, -N(R4)2, -NHR5, -N(R4)(R5), -NR4COOR4, -NHCOOR4, -NHCONHR3, -NHCSNHR3 or -NR3NH2 group, the symbol R6 represents a lower alkyl group or the two R6 symbols together represent a lower alkylene group, Y represents a leaving group and R1, R1, R1, R4 and R5 have the significance given above, with guanidine, or c) reductively removing the substituent denoted by X1 in a compound of the general formula (IV) wherein X1 represents a chlorine or bromine atom or a hydroxy group, R1 and R2 have the significance given in claim 1 and Z1 has the significance given above, or d) diazotising a compound of formula I in which Z represents an amino group and subsequently reacting the product with sodium azide, with an amine of the formula NH(R4)2 or with an alkali sulphite, or e) treating a compound of formula I in which Z represents a NHR4 group with nitrous acid, or f) converting the group Z2 in a compound of the general formula (Va) (Vb) or (Vc) , wherein R1 and R2 have the significance given above and Z2, which can be the same or different in formulae Vb and Vc, represents a group convertible by reduction or hydrolysis into an amino group or a -NHR4 group, into an amino group or a -NHR4 group, or g) alkylating or alkenylating the group denoted by Z3 in a compound of the general formula (Ia) wherein Z3 represents a -NHR5 or -NHCOOR4 group and R1, R2, R4 and R5 have the significance given above, and when required converting a compound of formula I obtained into a pharmaceutically acceptable salt thereof.
  2. 2. A process according to claim 1 for the manufacture of compounds of formula I in which n stands for zero, Z represents a nitro, amino, pyr-rolo, pyrrolidino, piperidino, -NHR4, -N(R4)2, -NHR5, -N(R4)(R5), -NR4COOR4, -NHCOOR4, -NHCONHR3, or -NHCSNHR3 group and R1, R2, R3, R4 and R5 have the significance given in claim 1, wherein a compound of formula IIa or IIb in which the symbol R6 represents a lower alkyl group and Z1, R1, R2, R3, R4 and R5 have the significance given in claim 1 is reacted with guanidine in accordance with embodiment (a).
  3. 3. A process according to claim 1 for the manufacture of compounds of formula I in which n stands for zero and Z has any of the values accorded to Z1 in claim 1, wherein the substituent denoted by X1 is reductively removed in accordance with embodiment (c) from a compound of formula IV in which X1 represents a chlorine or bromine atom, and Z1, R1 and R2 have the significance given in claim 1.
  4. 4. A process according to claim 1, wherein a compound of formula I
    in which n stands for zero, Z represents -N3 or -N=N-N(C1-3 alkyl)2 and R1 and R2 have the significance given in claim 1, is manufactured in accordance with embodiment (d).
  5. 5. A process according to claim 1, wherein a compound of formula I in which n stands for zero, Z represents an amino or -NH4 group and R1, R2 and R4 have the significance given in claim 1, is manufactured in accordance with embodiment (f).
  6. 6. A process according to claim 1, wherein a compound of formula I
    in which n stands for zero, Z represents a -N(R4)(R5) or -NR4COOR4 group and R1, R2, R4 and R5 have the significance given in claim 1, is manufactured in accordance with embodiment (g).
  7. 7. A process according to claim 1, wherein there is manufactured a compound of formula I in which R1 and R2 each represent a C1-3 alkoxy group, Z represents an amino group and n stands for zero.
  8. 8. A process according to claim 1, wherein there is manufactured .alpha.-(2,4-diamino-5-pyrimidinyl)-2',6'-dimethoxy-p-acetotoluidide by reacting 4'-(3-anilino-2-cyano-allyl)-2',6'-dimethoxy-acetanilide with guanidine in accord-ance with embodiment (a).
  9. 9. A process according to claim 1, wherein there is manufactured 2,4-diamino-5-(4-amino-3,5-dimethoxy-benzyl)-pyrimidine dihydrochloride by hydro-lysing .beta.-(2,4-diamino-5-pyrimidinyl)-2',6'-dimethoxy-p-acetotoluidide in ac-cordance with embodiment (f).
  10. 10. A process according to claim 1, wherein there is manufactured .alpha.-(2,4-diamino-5-pyrimidinyl)-2',6'-dimethoxy-N-methyl-p-acetotoluidide by re-acting 4'-(3-anilino-2-cyano-allyl)-2',6'-dimethoxy-N-methyl-acetanilide with guanidine in accordance with embodiment (a).
  11. 11. A process according to claim 1, wherein there is manufactured 2,4-diamino-5-(4-amino-3,5-dimethoxy-benzyl)-pyrimidine by reacting a compound se-lected from 4-amino-.alpha.-(anilino-methylene)-3,5-dimethoxy-hydrocinnamic acid nitrile, .alpha.-(4-amino-3,5-dimethoxy-benzyl)-4-morpholino-acrylonitrile, 4-amino-3,5-dimethoxy-.alpha.-(ethoxy-methyl)-cinnamic acid nitrile and 4'-(3-anilino-2-cyano-allyl)-2',6'-dimethoxy-formanilide with guanidine in accordance with embodiment (a).
  12. 12. A process according to claim 1, wherein there is manufactured 2,4-diamino-5-(4-amino-3,5-dimethoxy-benzyl)-pyrimidine by hydrolysing 4-[(2, 4-diamino-5-pyrimidinyl)-methyl]-2,6-dimethoxy-carbanilic acid ethyl ester in accordance with embodiment (f).
  13. 13. A process accordi.ng to claim 1, wherein there is manufactured 2,4-diamino-5-(4-amino-3,5-dimethoxy-benzyl)-pyrimidine by reductively remov-ing the chlorine atom from 2,4-diamino-5-(4-amino-3,5-dimethoxy-benzyl)-6-chloropyrimidine in accordance with embodiment (c).
  14. 14. A process according to claim 1, wherein there is manufactured 4-[(2,4-diamino-5-pyrimidinyl)-methyl]-2,6-dimethoxy-carbanilic acid ethyl ester by reacting 4-(3-anilino-2-cyano-allyl)-2,6-dimethoxy-carbanilic acid ethyl ester with guanidine in accordance with embodiment (a).
  15. 15. A process according to claim 1, wherein there is manufactured 2,4-diamino-5-[3,5-dimethoxy-4-(pyrrol-1-yl)-benzyl]-pyrimidine by reacting .alpha.-(anilino-methylene)-3,5-dimethoxy-4-(pyrrol-1-yl)-hydrocinnamic acid nitrile with guanidine in accordance with embodiment (a).
  16. 16. A process according to claim 1, wherein there is manufactured 2,4-diamino-5-(4-amino-3,5-diethoxy-benzyl)-pyrimidine by reacting 4-amino-.alpha.-(anilino-methylene)-3,5-diethoxy-hydrocinnamic acid nitrile with guanidine in accordance with embodiment (a).
  17. 17. A process according to claim 1, wherein there is manufactured 2,6-di-allyloxy-.alpha.-(2,4-diamino-5-pyrimidinyl)-p-acetotoluidide by reacting 2'6'-diallyloxy-4'-(3-anilino-2-cyano-allyl)-acetanilide with guanidine in accord-ance with embodiment (a).
  18. 18. A process according to claim 11, 12 or 13, wherein there is manu-factured 2,4-diamino-5-(4-amino 3,5-dimethoxy-benzyl)-pyrimidine hydro-chloride by treating 2,4-diamino-5-(4-amino-3,5-dimethoxy-benzyl)-pyrimidine with hydrochloric acid.
  19. 19. A process according to claim 1, wherein there is manufactured 2,4-diamino-5-(4-azido-3,5-dimethoxy-benzyl)-pyrimidine by diazotizing 2,4-di-amino-5-(4-amino-3,5-dimethoxy-benzyl)-pyrimidine and reacting the so produced diazonium compound with sodium azide in accordance with embodiment (d).
  20. 20. A process according to claim 1, wherein there is manufactured 2,4-diamino-5-[4-(3,3-diethyl-1-triazino)-3,5-dimethoxy-benzyl]-pyrimidine by diazotizing 2,4-diamino-5-(4-amino-3,5-dimethoxy-benzyl)-pyrimidine and re-acting the so produced diazonium compound with diethylamine in accordance with embodiment (d).
  21. 21. A process according to claim 1, wherein there is manufactured 4-[(2,4-diamino-5-pyrimidinyl)-methyl]-2,6-dimethoxy-N-methyl-carbanilic acid ethyl ester by N-methylating 4-[(2,4-diamino-5-pyrimidinyl)-methyl]-2,6-di-methoxy-carbanilic acid ethyl ester in accordance with embodiment (g).
  22. 22. A process according to claim 1, wherein there is manufactured N-ethyl-4-[(2,4-diamino-5-pyrimidinyl)-methyl]-2,6-dimethoxy-carbanilic acid ethyl ester by N-ethylating 4-[(2,4-diamino-5-pyrimidinyl)-methyl]-2,6-di-methoxy-carbanilic acid ethyl ester in accordance with embodiment (g).
  23. 23. A process according to claim 1, wherein there is manufactured 2,4-diamino-5-(4-dimethylamino-3,5-dimethoxy-benzyl)-pyrimidine by reacting .alpha.-(anilino-methylene)-4-dimethylamino-3,5-dimethoxy-hydrocinnamic acid nitrile with guanidine in accordance with embodiment (a).
  24. 24. A process according to claim 1, wherein there is manufactured 2,4-diamino-5-(3,5-dimethoxy-4-methylamino-benzyl)-pyrimidine by reacting .alpha.-(anilino-methylene)-3,5-dimethoxy-4-methylamino-hydrocinnamic acid nitrile with guanidine in accordance with embodiment (a).
  25. 25. A process according to claim 1, wherein there is manufactured 2,4-diamino-5-[3,5-dimethoxy-4-(methyl-nitrosoamino)-benzyl]-pyrimidine by treating 2,4-diamino-5-(3,5-dimethoxy-4-methylamino-benzyl)-pyrimidine with nitrous acid in accordance with embodiment (e).
  26. 26. A process according to claim 1, wherein there is manufactured 2,4-diamino-5-(4-ethylamino-3,5-dimethoxy-benzyl)-pyrimidine by reacting .alpha.-(anilino-methylene)-4-ethylamino-3,5-dimethoxy-hydrocinnamic acid nitrile with guanidine in accordance with embodiment (a).
  27. 27. A process according to claim 1, wherein there is manufactured 2,4-diamino-5-(4-amino-3,5-dimethyl-benzyl)-pyrimidine by reacting 4-amino-.alpha.-(anilino-methylene)-3,5-dimethyl-hydrocinnamic acid nitrile with guanidine in accordance with embodiment (a).
  28. 28. A process according to claim 1, wherein there is manufactured 2,4-diamino-5-(4-dimethylamino-3,5-dimethyl-benzyl)-pyrimidine by reacting .alpha.-(anilino-methylene)-4-dimethylamino-3,5-dimethyl-hydrocinnamic acid nitrile with guanidine in accordance with embodiment (a).
  29. 29. Compounds of general formula (I) defined in claim 1 and their pharmaceutically acceptable salts, when prepared by the process of claim 1 or by an obvious chemical equivalent thereof.
  30. 30. Benzylpyrimidine derivatives of formula (I) according to claim 1 in which n stands for zero, Z represents a nitro, amino, pyrrolo, pyrrolidino, piperidino, -NHR4, -N(R4)2, -NHR5 , -N(R4)(R5), -NR4COOR4, -NHCOOR4, -NHCONHR3, or -NHCSNHR3 group and R1, R2, R3, R4 and R5 have the significance given in claim 1, whenever prepared according to the process of claim 6 or by an obvious chemical equivalent thereof.
  31. 31. Benzylpyrimidine derivatives of formula (I) according to claim 1, wherein R1 and R2 each represent a C1-3 alkoxy group, Z represents an amino group and n stands for zero, whenever prepared by the process of claim 7 or by an obvious chemical equivalent thereof.
CA207,509A 1973-09-12 1974-08-21 Benzylpyrimidines Expired CA1037476A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1305773A CH591456A5 (en) 1973-09-12 1973-09-12

Publications (1)

Publication Number Publication Date
CA1037476A true CA1037476A (en) 1978-08-29

Family

ID=4388903

Family Applications (1)

Application Number Title Priority Date Filing Date
CA207,509A Expired CA1037476A (en) 1973-09-12 1974-08-21 Benzylpyrimidines

Country Status (28)

Country Link
JP (1) JPS6042238B2 (en)
AR (2) AR207764A1 (en)
AT (1) AT338797B (en)
BE (1) BE819773A (en)
BR (1) BR7407614D0 (en)
CA (1) CA1037476A (en)
CH (1) CH591456A5 (en)
CU (1) CU34115A (en)
DD (2) DD116824A5 (en)
DE (1) DE2443682C2 (en)
DK (1) DK135683B (en)
ES (7) ES429949A1 (en)
FI (1) FI58638C (en)
FR (1) FR2242984B1 (en)
GB (3) GB1484483A (en)
HK (1) HK181A (en)
HU (1) HU170427B (en)
IE (1) IE40523B1 (en)
IL (1) IL45510A (en)
LU (1) LU70878A1 (en)
NL (1) NL155827B (en)
NO (1) NO140858C (en)
PH (1) PH10643A (en)
PL (2) PL97757B1 (en)
SE (1) SE419443B (en)
SU (3) SU577987A3 (en)
YU (3) YU217874A (en)
ZA (1) ZA745317B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515948A (en) * 1973-09-12 1985-05-07 Hoffmann-La Roche Inc. 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
JPS5481278A (en) * 1977-10-18 1979-06-28 Wellcome Found Manufacture of triiseccaminomethane
CH639273A5 (en) * 1978-09-12 1983-11-15 Hoffmann La Roche DIURETIC MEANS.
DE3241134C2 (en) * 1981-11-09 1996-04-11 Mallinckrodt Veterinary Inc N Process for the preparation of 2,4-diamino-5-benzylpyrimidines and intermediates of the process
DE3250132C2 (en) * 1981-11-09 1997-01-16 Mallinckrodt Veterinary Inc 2,4-Di:amino-5-benzyl-pyrimidine derivs. prepn.
GB2180836A (en) * 1985-09-27 1987-04-08 William James Stephen Barker Sunscreen
JPH0431685Y2 (en) * 1987-06-01 1992-07-30
US4900859A (en) * 1987-12-03 1990-02-13 Hoffman-La Roche Inc. Process for 4-dimethylamino-3,5-dimethoxybenzaldehyde
CA1300166C (en) * 1987-12-03 1992-05-05 Alfredo Guerrato Process for the preparation of a benzoic acid ester

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1103931B (en) * 1957-02-21 1961-04-06 Wellcome Found Process for the preparation of 2,4-diamino-5-benzylpyrimidine derivatives
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes

Also Published As

Publication number Publication date
DE2443682A1 (en) 1975-03-20
YU37154B (en) 1984-08-31
DD116824A5 (en) 1975-12-12
LU70878A1 (en) 1976-08-19
ZA745317B (en) 1975-11-26
YU301680A (en) 1983-04-27
PL99159B1 (en) 1978-06-30
CU21022L (en) 1981-09-09
FR2242984A1 (en) 1975-04-04
YU217874A (en) 1982-06-18
DK135683C (en) 1977-11-14
HK181A (en) 1981-01-16
NL155827B (en) 1978-02-15
ES437011A1 (en) 1977-04-01
IE40523B1 (en) 1979-06-20
SU577987A3 (en) 1977-10-25
DE2443682C2 (en) 1983-11-10
YU37153B (en) 1984-08-31
AR211387Q (en) 1977-12-15
AU7263174A (en) 1976-02-26
BR7407614D0 (en) 1975-07-08
BE819773A (en) 1975-03-11
ES437013A1 (en) 1977-04-01
IE40523L (en) 1975-03-12
JPS5053385A (en) 1975-05-12
SE419443B (en) 1981-08-03
FI58638B (en) 1980-11-28
GB1484482A (en) 1977-09-01
PH10643A (en) 1977-07-22
NO743271L (en) 1975-04-07
SU571189A3 (en) 1977-08-30
ES437008A1 (en) 1977-04-01
NO140858C (en) 1979-11-28
ES437012A1 (en) 1977-04-01
IL45510A0 (en) 1974-11-29
YU301580A (en) 1983-04-27
PL97757B1 (en) 1978-03-30
DK468374A (en) 1975-05-12
FI58638C (en) 1981-03-10
DK135683B (en) 1977-06-06
FR2242984B1 (en) 1977-11-04
DD122785A5 (en) 1976-11-05
SE7411382L (en) 1975-03-13
JPS6042238B2 (en) 1985-09-20
CU34115A (en) 1983-10-04
AT338797B (en) 1977-09-12
ES437007A1 (en) 1977-04-01
FI256174A (en) 1975-03-13
GB1484483A (en) 1977-09-01
ES429949A1 (en) 1976-10-01
HU170427B (en) 1977-06-28
AR207764A1 (en) 1976-10-29
ATA735174A (en) 1977-01-15
NL7411685A (en) 1975-03-14
IL45510A (en) 1978-08-31
ES437009A1 (en) 1977-04-01
NO140858B (en) 1979-08-20
CH591456A5 (en) 1977-09-15
GB1484481A (en) 1977-09-01
SU609465A3 (en) 1978-05-30

Similar Documents

Publication Publication Date Title
NO851877L (en) NEW THERAPEUTICALLY EFFECTIVE PYRIMIDINE COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION.
US8404840B2 (en) Process for the preparation of endothelin receptor antagonists
CA1037476A (en) Benzylpyrimidines
US4515948A (en) 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
IE55898B1 (en) Antibacterial agents
US5550147A (en) Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
CA1070691A (en) Guanidine derivatives
US4438117A (en) 2-Substituted thio-4,5-diarylpyrimidines
IE63404B1 (en) Hydroxy and alkoxy pyrimidines
NZ207761A (en) Pyrimidine derivatives and pharmaceutical compositions
NO173441B (en) ANALOGY PROCEDURE FOR PREPARING NEW, THERAPEUTIC-ACTIVE PIPERAZINYLALKYL-3 (2H) -PYRIDAZINONES
NO852133L (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRROLIDINON DERIVATIVES.
SK286471B6 (en) 2-Phenylpyran-4-one derivatives, process for their preparation, pharmaceutical compositions containing them and their use
JPS6296481A (en) Manufacture of n-sulfamyl-3- (2-guanidino-thiazole-4-yl-methylthio)-propioneamidine
GB2082584A (en) Tetrazole derivatives
CA1141382A (en) 2-(1-piperazinyl)-cycloheptimidazole derivatives
US3441560A (en) Cyclopropyl-2-sulphanilamido-pyrimidines
GB2064515A (en) Heterocyclic derivatives processes for their production and pharmaceutical compositions containing them
NO774451L (en) PROCEDURE FOR PREPARING NEW SULFAMOYL BENZOIC ACIDS
MAKI et al. Studies on the Smiles rearrangement. XII. Synthesis and structural assignment of two isomeric N-phenyl-2, 3-diazaphenothiazinones
US4599346A (en) Propan-2-ol derivatives, a process for their production and medicaments containing these compounds
Vega et al. Thiophene isosteres: synthesis and biological evaluation of 3-substituted derivatives of 4-phenyl-2-thioxo-benzo [4, 5] thieno [2, 3-d] pyrimidine
PL72585B1 (en) 6-methyl-8-piperazinyl-methylergalene (ergoline) derivatives[us3583991a]
KR800000945B1 (en) Process for preparing benzylpyrimidines
Cheeseman et al. Pyrazines. Part IV. 2, 6-Dihydroxy-3, 5-diphenylpyrazine and related compounds